| UNITED      STATESSECURITIES      AND EXCHANGE COMMISSIONWashington,      D.C.  20549                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| FORM      10-K                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                             x  ANNUAL REPORT      PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934For      the fiscal year ended April 30, 2009or¨  TRANSITION REPORT      PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934For      the transition period from      ___________ to ___________ Commission      file number:  1-5865                                                                                                                                                                                                                                                                                                         |
| Gerber      Scientific, Inc.(Exact      name of registrant as specified in its charter)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Connecticut(State      or other jurisdiction of incorporation or organization)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |   | 06-0640743(I.R.S.      Employer Identification No.)  |
| 83      Gerber Road West, South Windsor, Connecticut(Address      of principal executive offices)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |   | 06074(Zip      Code) |
|  Registrant's      telephone number, including area code:  (860)      644-1551                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Securities      registered pursuant to Section 12(b) of the Act:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Title of each      class                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   | Name of each exchange      on which registered |
| Common      Stock, par value $0.01 per share                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   | New      York Stock Exchange |
| Securities      registered pursuant to Section 12(g) of the      Act:  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Indicate      by check mark if the registrant is a well-known seasoned issuer, as      defined in Rule 405 of the Securities Act.  Yes ¨   No      þ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Indicate      by check mark if the registrant is not required to file reports pursuant      to Section 13 or Section 15(d) of the Act.  Yes ¨   No      þ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Indicate      by check mark whether the registrant (1) has filed all reports required to      be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934      during the preceding 12 months (or for such shorter period that the      registrant was required to file such reports), and (2) has been subject to      such filing requirements for the past 90 days.          Yes þ   No      ¨                                                                                                                                                                                                                                                                                                                                                                                               |
| Indicate      by check mark whether the registrant has submitted electronically and      posted on its corporate Website, if any, every Interactive Data File      required to be submitted and posted pursuant to Rule 405 of Regulation S-T      during the preceding 12 months (or for such shorter period that the      registrant was required to submit and post such      files).     Yes ¨   No      ¨                                                                                                                                                                                                                                                                                                                                                                                        |
| Indicate      by check mark if disclosure of delinquent filers pursuant to Item 405 of      Regulation S-K is not contained herein, and will not be contained, to the      best of registrant's knowledge, in definitive proxy or information      statements incorporated by reference in Part III of this Form 10-K or any      amendment to this Form 10-K.  o                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Indicate      by check mark whether the registrant is a large accelerated filer, an      accelerated filer, a non-accelerated filer, or a smaller reporting      company.  See the definitions of "large accelerated filer,"      "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the      Exchange Act.  Large      accelerated filer ¨               Accelerated      filer þ                         Non-accelerated      filer ¨                   Smaller      reporting company ¨  |
| Indicate      by check mark whether the registrant is a shell company (as defined in      Rule 12-b2 of the Act.)     Yes ¨   No      þ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| The      aggregate market value of Gerber Scientific, Inc. common stock held by      non-affiliates as of October 31, 2008, which was the last business day of      the registrant's most recently completed second quarter, based on the      reported closing price of the common stock on the New York Stock Exchange      on such date, was approximately $111,643,198.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 24,608,644      shares of common stock of the registrant were outstanding as of June 30,      2009, exclusive of treasury shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Documents incorporated by      reference:  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| GERBER      SCIENTIFIC, INC.Index      to Annual Reporton      Form 10-KFiscal      Year Ended April 30, 2009                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| PART      I                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | PAGE |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |   |   |
| Item      1.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Business | 4-15 |
| Item      1A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Risk Factors | 15-22 |
| Item      1B.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Unresolved Staff Comments | 22 |
| Item      2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | Properties | 22 |
| Item      3.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Legal Proceedings | 23 |
| Item      4.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Submission of Matters to a Vote of Security      Holders | 23 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Executive Officers of the      Registrant | 24 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |   |   |
| PART      II                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |   |   |
| Item      5.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Market for Registrant's Common Equity, Related Stockholder      Matters and IssuerPurchases of Equity Securities | 25-27 |
| Item      6.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Selected Financial Data | 27 |
| Item      7.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Management's Discussion and Analysis of Financial Condition      and Results of Operations | 28-45 |
| Item      7A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Quantitative and Qualitative Disclosures About Market      Risk | 45 |
| Item      8.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Financial Statements and Supplementary    Data | 45 |
| Item      9.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Changes in and Disagreements With Accountants on Accounting      and Financial Disclosure | 45 |
| Item      9A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Controls and Procedures | 46 |
| Item      9B.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Other Information | 46-47 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |   |   |
| PART      III                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |   |   |
| Item      10.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Directors, Executive Officers and Corporate      Governance | 48-49 |
| Item      11.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Executive Compensation | 50-71 |
| Item      12.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Security Ownership of Certain Beneficial Owners and      Management and Related Stockholder Matters | 71-74 |
| Item      13.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Certain Relationships and Related Transactions, and      Director Independence | 75 |
| Item      14.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Principal Accounting Fees and Services | 75-76 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |   |   |
| PART      IV                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |   |   |
| Item      15.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Exhibits, Financial StatementSchedules | 77-112 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |   |   |
| Signatures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 113 |

----

----

ITEM

----

|                                    |                                        | For      the fiscal year ended April 30, 2009 |
|-----------------------------------------|---------------------------------------------|----------------------------------------------------|
| Operating      Segment                  | Principal      Business Unit(s)             | Revenue (in      millions)                    |   | Percent      ofRevenue |
| Sign      Making and Specialty Graphics | Gerber      Scientific Products and Spandex |                                               | $ | 320.7 |   |   |   | 58 | % |
| Apparel      and Flexible Materials     | Gerber      Technology                      |                                               |   | 174.6 |   |   |   | 32 | % |
| Ophthalmic      Lens Processing         | Gerber      Coburn                          |                                               |   | 57.5 |   |   |   | 10 | % |
|                                    |                                        |                                               | $ | 552.8 |   |   |   | 100 | % |

----

----

----

| ·   | conceptual      design, advanced CAD pattern-making, and marking or nesting      software; |
|--------------------|--------------------------------------------------------------------------------------------|

| ·   | pattern      design digitizers and large formatplotters; |
|--------------------|----------------------------------------------------------|

| ·   | CAM      material spreading and single- and multi-ply cutting    systems; |
|--------------------|---------------------------------------------------------------------------|

| ·   | product      lifecycle management, or "PLM," and product data management, or "PDM,"      software, which are enterprise-wide applications used by apparel brands      and retailers for global management of product activities and which      facilitate communication of measurement specifications, construction      details, costing and bill of material information among apparel and other      flexible materials designers, raw materials suppliers, makers of the      materials and retailers; |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | precision      laser-based templating, inspection, marking and engraving      solutions; |
|--------------------|------------------------------------------------------------------------------------------|

| ·   | aftermarket      supplies, including spare parts and consumable materials;    and |
|--------------------|-----------------------------------------------------------------------------------|

| ·   | customer      training, technical support and comprehensive maintenance and specialized      support services. |
|--------------------|----------------------------------------------------------------------------------------------------------------|

| Apparel      and retail                  |   |   | 57 | % |
|------------------------------------------|--------|--------|----|---|
| Industrial      and aerospace composites |   |   | 27 | % |
| Transportation      interiors            |   |   | 10 | % |
| Furniture                                |   |   | 6  | % |

----

----

----

----

----

----

|                                    | April      30, |
|-----------------------------------------|----------------|
| In      thousands                       |           | 2009 |   |   | 2008 |   |
| Sign      Making and Specialty Graphics |           | $ | 1,967 |   |   | $ | 3,462 |   |
| Apparel      and Flexible Materials     |           |   | 22,894 |   |   |   | 33,770 |   |
| Ophthalmic      Lens Processing         |           |   | 1,200 |   |   |   | 1,440 |   |
|                                    |           | $ | 26,061 |   |   | $ | 38,672 |   |

----

ITEM

----

| ·   | the      pursuit of ultimately unconsummated acquisitions and the integration of      acquired businesses could significantly strain management, financial and      other resources and divert limited resources from regular      operations; |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | acquisitions      may not have an immediate positive impact on Gerber's cash flows or      results of operations due to transaction-related expenses or higher      operating and administrative expenses that may be incurred during the      integration period immediately following the  acquisitions; |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Gerber      may not be able to achieve the synergies and cost savings anticipated to      result from any acquisition; |
|--------------------|------------------------------------------------------------------------------------------------------------------------|

----

| ·   | Gerber's      operating and financial systems and controls and information services may      not be compatible with those of acquired companies or adequate to support      integration efforts and any steps taken to improve these systems and      controls may not be sufficient; |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | acquisitions      could increase Gerber's need for qualified personnel, who may not be      available; and |
|--------------------|------------------------------------------------------------------------------------------------------------|

| ·   | acquired      businesses may have unexpected liabilities and contingencies, which could      be significant. |
|--------------------|--------------------------------------------------------------------------------------------------------------|

| ·   | general      geopolitical risks, such as political and economic instability and changes      in diplomatic and traderelationships; |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------|

| ·   | imposition      of or increases in currency exchangecontrols; |
|--------------------|---------------------------------------------------------------|

| ·   | potential      inflation in the applicable foreigneconomies; |
|--------------------|--------------------------------------------------------------|

| ·   | imposition      of or increases in import duties and other tariffs on products;      and |
|--------------------|------------------------------------------------------------------------------------------|

| ·   | imposition      of or increases in foreign taxation of earnings and withholding on      payments received fromsubsidiaries. |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------|

| ·   | make      it more difficult for Gerber to satisfy its financial      obligations; |
|--------------------|-----------------------------------------------------------------------------------|

| ·   | require      Gerber to dedicate a substantial portion of its cash flow from operations      to payments on its indebtedness; |
|--------------------|------------------------------------------------------------------------------------------------------------------------------|

| ·   | limit      Gerber’s ability to react to changes to the economy or in its business or      industry; and |
|--------------------|---------------------------------------------------------------------------------------------------------------|

| ·   | place      Gerber at a competitive disadvantage relative to companies that have less      indebtedness. |
|--------------------|---------------------------------------------------------------------------------------------------------|

----

| ·   | incur      additional indebtedness, create liens and make  investments; |
|--------------------|-------------------------------------------------------------------------|

| ·   | pay      dividends on or redeem or repurchase capital stock, and issue or sell      stock of subsidiaries; and |
|--------------------|----------------------------------------------------------------------------------------------------------------|

| ·   | engage      in sale-leaseback transactions, sell assets and engage in mergers, sales,      acquisitions and consolidations. |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------|

----

| ·   | changes      in general economic conditions and specific conditions in industries in      which Gerber's businesses operate that can result in the deferral or      reduction of purchases by end-usecustomers; |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | changes      in the level of global corporate spending on technologies due to such      economic conditions; |
|--------------------|--------------------------------------------------------------------------------------------------------------|

| ·   | the      effects of terrorist activity and international conflicts, which could      lead to business interruptions; |
|--------------------|----------------------------------------------------------------------------------------------------------------------|

| ·   | the      size and timing of significant orders, which can be      non-recurring; |
|--------------------|----------------------------------------------------------------------------------|

| ·   | product      configuration and mix; |
|--------------------|-------------------------------------|

| ·   | market      acceptance of new products and product  enhancements; |
|--------------------|-------------------------------------------------------------------|

| ·   | announcements,      introductions and transitions of new products by Gerber or Gerber's      competitors; |
|--------------------|-----------------------------------------------------------------------------------------------------------|

| ·   | deferrals      of customer orders in anticipation of new products or product enhancements      introduced by Gerber or Gerber'scompetitors; |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | changes      in pricing in response to competitive pricing  actions; |
|--------------------|----------------------------------------------------------------------|

| ·   | supply      constraints; |
|--------------------|--------------------------|

| ·   | the      level of expenditures on research and development and sales and marketing      programs; |
|--------------------|---------------------------------------------------------------------------------------------------|

| ·   | Gerber's      ability to achieve targeted costreductions; |
|--------------------|-----------------------------------------------------------|

| ·   | rising      interest rates; and |
|--------------------|---------------------------------|

| ·   | costs      associated with excess capacity and/or idle  facilities. |
|--------------------|---------------------------------------------------------------------|

----

----

----

ITEM

ITEM

| Type      of Facility                                                   | Location                                                                                                                                                                                                                                   | Square      Feet |
|-------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------|
|                                                                    |                                                                                                                                                                                                                                       |             |
| Corporate      headquarters / manufacturing / office (L) (1,3)          | South      Windsor, Connecticut                                                                                                                                                                                                            | 250,000          |
| Manufacturing      / office (O) (1,2,3)                                 | Tolland,      Connecticut                                                                                                                                                                                                                  | 224,000          |
| Manufacturing      / office (L) (4)                                     | Manchester,      Connecticut                                                                                                                                                                                                               | 118,000          |
| Manufacturing      / office (O) (1)                                     | Lancaster,      England                                                                                                                                                                                                                    | 125,000          |
| Manufacturing      / office (L) (2)                                     | Ikast,      Denmark                                                                                                                                                                                                                        | 39,000           |
| Manufacturing      / office (O) (1)                                     | Achern,      Germany                                                                                                                                                                                                                       | 56,000           |
| Warehouse      / sales and service office (L) (1,4)                     | Bristol,      England                                                                                                                                                                                                                      | 110,000          |
| Manufacturing      / warehouses / sales and service offices (L) (1,2,3) | Various                                                                                                                                                                                                                                    | 653,000          |
| (O)                                                                     | Company-owned                                                                                                                                                                                                                              |
| (L)                                                                     | Leased                                                                                                                                                                                                                                     |
| (1)                                                                     | Sign      Making and Specialty Graphics                                                                                                                                                                                                    |
| (2)                                                                     | Apparel      and Flexible Materials                                                                                                                                                                                                        |
| (3)                                                                     | Ophthalmic      Lens Processing                                                                                                                                                                                                            |
| (4)                                                                     | As      of April 30, 2009, the Company sublet 6,505 square feet in Manchester,      Connecticut and 45,145 square feet in Bristol, England to independent      third parties.  These subleases expire over various      periods. |

----

ITEM

ITEM

----

EXECUTIVE

| Name                         | Age    | Position      as of April 30, 2009and      Date of Initial Appointment                                                   | Other      Business Experience Since April 30, 2004                                                                                                                                                                                                                                                                                                                                                                                                |
|------------------------------|--------|--------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Marc      T. Giles           | 53     | President      and Chief Executive Officer (November 29, 2001)                                                           | ---                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                         |   |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Michael      R. Elia         | 50     | Executive      Vice President and Chief Financial Officer (April 15,2008)                                                | Chief      Financial Officer, Risk Management Solutions, Inc. (January 2008 – April      2008), a specialty service provider for the insured and alternative risk      marketplace; Senior Vice President and Chief Financial Officer of      FastenTech, Inc. (January 2004 - December 2007), a global metal products      manufacturer; Owner, private financial and marketing services consulting      company (May 2003 - December 2004) |
|                         |   |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| James      S. Arthurs        | 65     | Senior      Vice President (September 30, 2002); President Asia-Pacific, Gerber      Scientific, Inc. (February 1, 2005) | President,      Gerber Technology (September 2002 - January 2005)                                                                                                                                                                                                                                                                                                                                                                                  |
|                         |   |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| William      V. Grickis, Jr. | 58     | Senior      Vice President and General Counsel (October 1, 2003); Secretary (November      20, 2003)                     | ---                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                         |   |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| John      R. Hancock         | 62     | Senior      Vice President (December 7, 2001); President, Gerber Technology (February      1, 2005)                      | President,      Gerber Coburn Optical (December 2001 - February 2005)                                                                                                                                                                                                                                                                                                                                                                              |
|                         |   |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Alex      F. Incera          | 45     | President,      Gerber Coburn (September 25, 2008)                                                                       | General      Manager, Gerber Coburn (January 2008 – September 24, 2008); Executive      Director of Marketing, Gerber Coburn (October 2006 – January 2008); Vice      President of Engineering, Gerber Coburn (March 1999-October      2006)                                                                                                                                                                            |
|                         |   |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| John      J. Krawczynski     | 37     | Vice      President, Chief Accounting Officer and Corporate Controller (September 5,      2005)                          | Controller,      Lydall, Inc. (May 2004 - August 2005), manufacturer of thermal/acoustical      and filtration/separation products                                                                                                                                                                                                                                                                                                                 |
|                         |   |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Rodney      W. Larson        | 51     | Senior      Vice President (May 1, 2007); President, Spandex (July 1,      2007)                                         | President,      Gerber Coburn (March 2006 – July 2007); Independent consultant (2005 –      April 2007); VP, Sales and Marketing, Key Technology (2003 - 2005),      developer of automated inspection, sorting and material conveying      solutions for process industries                                                                                                                                                           |
|                         |   |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Stephen      P. Lovass       | 39     | Senior      Vice President; President, Gerber Scientific Products (February 11,      2008)                               | President,      Gerber Coburn (July 1, 2007 – September 24, 2008); Vice President;      President, Spandex (November 2006); Interim Group Managing Director,      Spandex  (February 2005 - November 2006); VP, Marketing and      Business Development, Spandex (April 2004 - February  2005)                                                                                                                                     |
|                         |   |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Joseph      R. Mele          | 57     | Senior      Vice President, Operations (January 2, 2008)                                                                 | Partner,      Lean Horizons Consulting (January 2006 - December 2007); Partner,      Accenture (February 1998 – December 2005), global management consulting,      technology services and outsourcing company                                                                                                                                                                                                                               |
|                         |   |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Jay      Wickliff 1          | 57     | Vice      President; Global Human Resources (September 1, 2006)                                                          | Executive      Director, Human Resources (January 2002 - September  2006)                                                                                                                                                                                                                                                                                                                                                                          |

----

ITEM

|                |   | High   |   |   | Low    |   |   | Close  |   |
|---------------------|--------|--------|--------|--------|--------|--------|--------|--------|--------|
| Fiscal      2009    |   |   |   |   |   |   |   |   |   |   |
| First      Quarter  |   | $      | 12.64  |   |   | $      | 8.74   |   |   | $ | 11.87 |   |
| Second      Quarter |   | $      | 12.00  |   |   | $      | 4.18   |   |   | $ | 4.78 |   |
| Third      Quarter  |   | $      | 5.50   |   |   | $      | 1.79   |   |   | $ | 3.14 |   |
| Fourth      Quarter |   | $      | 3.98   |   |   | $      | 1.65   |   |   | $ | 3.95 |   |
| Fiscal      2008    |   |   |   |   |   |   |   |   |   |   |   |   |
| First      Quarter  |   | $      | 13.25  |   |   | $      | 9.76   |   |   | $ | 10.38 |   |
| Second      Quarter |   | $      | 11.94  |   |   | $      | 9.74   |   |   | $ | 11.05 |   |
| Third      Quarter  |   | $      | 11.24  |   |   | $      | 8.25   |   |   | $ | 8.80 |   |
| Fourth      Quarter |   | $      | 9.68   |   |   | $      | 7.56   |   |   | $ | 9.27 |   |

| Period                                             |   | (a)TotalNumberof      Shares(or      Units)Purchased |   |   | (b)AveragePricePaid      perShare(or      Unit) |   | (c)Total      Number ofShares      (or Units)Purchased      as Partof      PubliclyAnnounced      Plansor      Programs | (d)MaximumNumber      (orApproximateDollar      Value)of      Shares (or Units)that      May Yet BePurchased      Under thePlans      or Program |
|----------------------------------------------------|--------|------------------------------------------------------|--------|--------|-------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|
| February      1, 2009 – February 28, 2009    |   |                                                 | ---    |   |                                            |   | ---                                                                                                                     |                                                                                                                                             | Not      applicable | Not      applicable |
| March      1, 2009 – March 31, 2009 (1) |   |                                                 | 331    |   |                                            | $      | 1.87                                                                                                                    |                                                                                                                                             | Not      applicable | Not      applicable |
| April      1, 2009 – April 30, 2009          |   |                                                 | ---    |   |                                            |   | ---                                                                                                                     |                                                                                                                                             | Not      applicable | Not      applicable |
|                                               |   |                                                 | 331    |   |                                            | $      | 1.87                                                                                                                    |                                                                                                                                             | Not      applicable | Not      applicable |

----

|                                   |   | Apr-04 |   |   | Apr-05 |   |   | Apr-06 |   |   | Apr-07 |   |   | Apr-08 |   |   | Apr-09 |   |
|----------------------------------------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|
| Gerber      Scientific, Inc.           |   |   | 100.00 |   |   |   | 118.00 |   |   |   | 172.83 |   |   |   | 166.83 |   |   |   | 154.50 |   |   |   | 65.83 |   |
| S&P      Smallcap 600              |   |   | 100.00 |   |   |   | 110.43 |   |   |   | 145.10 |   |   |   | 156.19 |   |   |   | 142.07 |   |   |   | 99.37 |   |
| Dow      Jones US Electronic Equipment |   |   | 100.00 |   |   |   | 95.62  |   |   |   | 133.48 |   |   |   | 141.65 |   |   |   | 147.81 |   |   |   | 101.59 |   |

----

ITEM 6

|                                                                                | For      the Fiscal Years Ended April 30, |   |
|-------------------------------------------------------------------------------------|-------------------------------------------|--------|
| In      thousands except per share amounts                                          |                                      | 2009   |   | 2008 |   | 2007 |   | 2006 |   |   | 2005 |   |
| Revenue                                                                             |                                      | $      | 552,814 |   |   | $ | 640,017 |   |   | $ | 574,798 |   |   | $ | 530,418 |   |   | $ | 517,322 |   |
| Income      (loss) before cumulative effect of a change inaccounting      principle |                                      | $      | 2,236 |   |   | $ | 14,504 |   |   | $ | 13,508 |   |   | $ | 2,984 |   |   | $ | (5,638 | ) |
| Per      common share:                                                              |                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic                                                                               |                                      | $      | 0.09 |   |   | $ | 0.62 |   |   | $ | 0.59 |   |   | $ | 0.13 |   |   | $ | (0.25 | ) |
| Diluted                                                                             |                                      | $      | 0.09 |   |   | $ | 0.61 |   |   | $ | 0.58 |   |   | $ | 0.13 |   |   | $ | (0.25 | ) |
| Net      income (loss)                                                              |                                      | $      | 2,236 |   |   | $ | 14,504 |   |   | $ | 13,508 |   |   | $ | 2,644 |   |   | $ | (5,638 | ) |
| Per      common share:                                                              |                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic                                                                               |                                      | $      | 0.09 |   |   | $ | 0.62 |   |   | $ | 0.59 |   |   | $ | 0.12 |   |   | $ | (0.25 | ) |
| Diluted                                                                             |                                      | $      | 0.09 |   |   | $ | 0.61 |   |   | $ | 0.58 |   |   | $ | 0.12 |   |   | $ | (0.25 | ) |
| Total      assets                                                                   |                                      | $      | 359,217 |   |   | $ | 378,539 |   |   | $ | 335,962 |   |   | $ | 310,480 |   |   | $ | 313,319 |   |
| Long-term      debt (includes current maturities)                                   |                                      | $      | 73,500 |   |   | $ | 42,000 |   |   | $ | 31,836 |   |   | $ | 37,120 |   |   | $ | 45,742 |   |
| Shareholders'      equity                                                           |                                      | $      | 148,302 |   |   | $ | 169,563 |   |   | $ | 144,481 |   |   | $ | 125,616 |   |   | $ | 115,715 |   |

----

ITEM

| ·   | expected      financial condition, future earnings, levels of growth, or other measures      of financial performance, or the future size of market segments or      geographic markets; |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | economic      conditions; |
|--------------------|---------------------------|

| ·   | planned      cost reductions; |
|--------------------|-------------------------------|

| ·   | future      cash flows and uses of cash and debt reduction  strategies; |
|--------------------|-------------------------------------------------------------------------|

| ·   | prospective      product developments and business growth opportunities, as well as      competitor product developments; |
|--------------------|---------------------------------------------------------------------------------------------------------------------------|

| ·   | demand      for Gerber's products and services; |
|--------------------|-------------------------------------------------|

| ·   | methods      of and costs associated with potential geographic    expansion; |
|--------------------|------------------------------------------------------------------------------|

| ·   | regulatory      and market developments and the impact of such developments on future      operating results; |
|--------------------|---------------------------------------------------------------------------------------------------------------|

| ·   | potential      impacts from credit market risk; |
|--------------------|-------------------------------------------------|

| ·   | future      effective income tax rates; |
|--------------------|-----------------------------------------|

| ·   | the      outcome of contingencies; |
|--------------------|------------------------------------|

| ·   | the      availability and cost of raw materials;and |
|--------------------|-----------------------------------------------------|

| ·   | pension      plan assumptions and futurecontributions. |
|--------------------|--------------------------------------------------------|

| ·   | Overview and Outlook -      a brief summary of fiscal 2009 results and trends and expectations for      future periods. |
|--------------------|-------------------------------------------------------------------------------------------------------------------------|

| ·   | Results of Operations      and Segment      Review - an analysis of Gerber's consolidated results of operations      for the three years presented in the consolidated financial statements and      by reportable segment. |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Financial Condition -      an analysis of Gerber's liquidity and capital resources, cash flows,      off-balance sheet arrangements, aggregate contractual obligations, and an      overview of the financial position. |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Critical Accounting Estimates      - a description of accounting policies that require critical      judgment and estimates. |
|--------------------|------------------------------------------------------------------------------------------------------------------------------|

----

| ·   |  Sign      Making and Specialty Graphics (Gerber Scientific Products and Spandex      business units); |
|--------------------|-------------------------------------------------------------------------------------------------------------|

| ·   | Apparel      and Flexible Materials (Gerber Technology);and |
|--------------------|-------------------------------------------------------------|

| ·   | Ophthalmic      Lens Processing (Gerber Coburn). |
|--------------------|--------------------------------------------------|

|                                    | For      the Fiscal Years Ended April 30, |   |
|-----------------------------------------|-----------------------------------------------------|--------|
| In      thousands                       |                                                | 2009   |   |   | 2008 |   |   | 2007 |   |
| Sign      Making and Specialty Graphics |                                                | $      | 320,705 |   |   | $ | 361,086 |   |   | $ | 302,087 |   |
| Apparel      and Flexible Materials     |                                                |   | 174,566 |   |   |   | 207,945 |   |   |   | 196,164 |   |
| Ophthalmic      Lens Processing         |                                                |   | 57,543 |   |   |   | 70,986 |   |   |   | 76,547 |   |
| Revenue                            |                                                | $      | 552,814 |   |   | $ | 640,017 |   |   | $ | 574,798 |   |

----

|                                                           |   | For      the Fiscal Years Ended April 30, |   |   |
|----------------------------------------------------------------|--------|-----------------------------------------------------|--------|--------|
|                                                           |   | 2009                                                |   |   |   | 2008 |   |   |   | 2007 |   |   |
| Gross      profit margin                                       |   |                                                | 27.9   |   | % |   |   | 29.1 |   | %  |   |   | 30.0 |   |  % |
| Selling,      general and administrative ("SG&A") expenses |   |                                                | (22.7  | )      | % |   |   | (21.1 | ) | %  |   |   | (21.7 | ) | % |
| Research      and development                                  |   |                                                | (4.1   | )      | % |   |   | (4.1 | ) | %  |   |   | (4.2 | ) | % |
| Operating      income                                          |   |                                                | 1.1    |   | % |   |   | 3.9 |   | %  |   |   | 4.1 |   |  % |

|                                              | For      the Fiscal Years Ended April 30, |   |
|---------------------------------------------------|-----------------------------------------------------|--------|
| In      thousands                                 |                                                | 2009   |   |   | 2008 |   |   | 2007 |   |
| Revenue                                           |                                                | $      | 552,814 |   |   | $ | 640,017 |   |   | $ | 574,798 |   |
| Cost      of sales                                |                                                |   | 398,436 |   |   |   | 453,484 |   |   |   | 402,424 |   |
| Gross      profit                                 |                                                |   | 154,378 |   |   |   | 186,533 |   |   |   | 172,374 |   |
| Selling,      general and administrative expenses |                                                |   | 125,726 |   |   |   | 135,297 |   |   |   | 124,460 |   |
| Research      and development                     |                                                |   | 22,417 |   |   |   | 26,187 |   |   |   | 24,282 |   |
| Operating      income                             |                                                | $      | 6,235 |   |   | $ | 25,049 |   |   | $ | 23,632 |   |

----

|                                |   | For      the Fiscal Years Ended April 30, |    |
|-------------------------------------|--------|-------------------------------------------|---------|
| In      thousands                   |   | 2009                                      |    |   | 2008 |   |   | 2007 |   |
| Equipment      and software revenue |   | $                                         | 159,505 |   | 29 | % |   | $ | 205,180 |   | 32 | % |   | $ | 192,166 |   | 33 | % |
| Aftermarket      supplies revenue   |   |                                      | 319,857 |   | 58 | % |   |   | 360,765 |   | 56 | % |   |   | 316,975 |   | 55 | % |
| Service      revenue                |   |                                      | 73,452  |   | 13 | % |   |   | 74,072 |   | 12 | % |   |   | 65,657 |   | 12 | % |
| Revenue                             |   | $                                         | 552,814 |   | 100 | % |   | $ | 640,017 |   | 100 | % |   | $ | 574,798 |   | 100 | % |

|                                    | For      the Fiscal Years Ended April 30, |   |
|-----------------------------------------|-------------------------------------------|--------|
|                                    |                                      | 2009   |   | 2008 |   | 2007 |   |
| Sign      Making and Specialty Graphics |                                      |   | 58 | % | 56 | % | 53 | % |
| Apparel      and Flexible Materials     |                                      |   | 32 | % | 33 | % | 34 | % |
| Ophthalmic      Lens Processing         |                                      |   | 10 | % | 11 | % | 13 | % |
|                                    |                                      |   | 100 | % | 100 | % | 100 | % |

----

|               |   | For      the Fiscal Years Ended April 30, |
|--------------------|--------|-------------------------------------------|
| In      thousands  |   | 2009                                      |   |   | 2008 |   |   | 2007 |
| North      America |   | $                                         | 215,765 |   | 39.0 | % |   | $ | 208,225 |   | 32.5 | % |   | $ | 197,451 |   | 34.4 | % |
| Europe             |   |                                      | 248,524 |   | 45.0 | % |   |   | 292,252 |   | 45.7 | % |   |   | 243,564 |   | 42.4 | % |
| Rest      of World |   |                                      | 88,525 |   | 16.0 | % |   |   | 139,540 |   | 21.8 | % |   |   | 133,783 |   | 23.2 | % |
| Revenue            |   | $                                         | 552,814 |   | 100.0 | % |   | $ | 640,017 |   | 100.0 | % |   | $ | 574,798 |   | 100.0 | % |

|                     | For      the Fiscal Years Ended April 30, |
|--------------------------|-----------------------------------------------------|
| In      thousands        | 2009                                                |   |   | 2008 |   | 2007 |   |
| Gross      profit        | $                                                   | 154,378 |   |   | $ | 186,533 |   | $ | 172,374 |   |
| Gross      profit margin |                                                | 27.9 | % |   |   | 29.1 | % |   | 30.0 | % |

----

|                                              |   | For      the Fiscal Years Ended April 30, |    |
|---------------------------------------------------|--------|-------------------------------------------|---------|
| In      thousands                                 |   | 2009                                      |    |   | 2008 |   | Change |   | 2008 | 2007  | Change |   |
| Selling,      general and administrative expenses |   | $                                         | 125,726 |   |   | $ | 135,297 |   | (7.1 | %) |   | $ | 135,297 | $ | 124,460 | 8.7 | % |

|                                               |   | For      the Fiscal Years Ended April 30, |
|----------------------------------------------------|--------|-------------------------------------------|
| In      thousands                                  |   | 2009                                      |   |   | 2008 |   | Change |   | 2008 |   | 2007 |   | Change |
| Research      and development expenses ("R&D") |   | $                                         | 22,417 |   |   | $ | 26,187 |   | (14.4 | % | )  | $ | 26,187 |   | $ | 24,282 |   | 7.8 | % |

|                             | For      the Fiscal Years Ended April 30, |   |
|----------------------------------|-------------------------------------------|--------|
| In      thousands                |                                      | 2009   |   |   | 2008 |   |   | 2007 |   |
| Other      income (expense), net |                                      | $      | (4,190 | ) |   | $ | (132 | ) |   | $ | 524 |   |

----

|                                                 | For      the Fiscal Years Ended April 30, |   |
|------------------------------------------------------|-------------------------------------------|--------|
| In      thousands                                    |                                      | 2009   |   |   | 2008 |   |   | 2007 |   |
| Interest      expense                                |                                      | $      | 3,746 |   |   | $ | 4,165 |   |   | $ | 3,530 |   |
| Weighted-average      credit facility interest rates |                                      |   | 5.7 | % |   |   | 8.6 | % |   |   | 9.5 | % |

|                    | For      the Fiscal Years Ended April 30, |   |
|-------------------------|-------------------------------------------|--------|
|                    |                                      | 2009   |   |   | 2008 |   |   | 2007 |   |
| Effective      tax rate |                                      |   | 231.5 | % |   |   | 30.1 | % |   |   | 34.5 | % |

----

|                         |   | For      the Fiscal Years Ended April 30, |
|------------------------------|--------|-------------------------------------------|
|                         |   | 2009                                      |   |   | 2008 |   |   | 2007 |
| In      thousands            |   | GSP                                       |   |   | Spandex |   |   | Total |   |   | GSP |   |   | Spandex |   |   | Total |   |   | GSP |   |   | Spandex |   |   | Total |   |
| Revenue                      |   | $                                         | 89,712 |   |   | $ | 230,993 |   |   | $ | 320,705 |   |   | $ | 102,689 |   |   | $ | 258,397 |   |   | $ | 361,086 |   |   | $ | 89,357 |   |   | $ | 212,730 |   |   | $ | 302,087 |   |
| Operating      income (loss) |   | $                                         | (1,741 | ) |   | $ | 9,559 |   |   | $ | 7,818 |   |   | $ | 1,376 |   |   | $ | 10,592 |   |   | $ | 11,968 |   |   | $ | 5,199 |   |   | $ | 6,419 |   |   | $ | 11,618 |   |

----

|                          | For      the Fiscal Years Ended April 30, |   |
|-------------------------------|-------------------------------------------|--------|
| In      thousands             |                                      | 2009   |   |   | 2008 |   |   | 2007 |   |
| Segment      revenue          |                                      | $      | 174,566 |   |   | $ | 207,945 |   |   | $ | 196,164 |   |
| Segment      operating profit |                                      | $      | 12,059 |   |   | $ | 26,681 |   |   | $ | 27,601 |   |

----

|                          | For      the Fiscal Years Ended April 30, |   |
|-------------------------------|-------------------------------------------|--------|
| In      thousands             |                                      | 2009   |   |   | 2008 |   |   | 2007 |   |
| Segment      revenue          |                                      | $      | 57,543 |   |   | $ | 70,986 |   |   | $ | 76,547 |   |
| Segment      operating profit |                                      | $      | 3,198 |   |   | $ | 4,384 |   |   | $ | 2,913 |   |

|                              | For      the Fiscal Years Ended April 30, |   |
|-----------------------------------|-------------------------------------------|--------|
| In      thousands                 |                                      | 2009   |   |   | 2008 |   |   | 2007 |   |
| Corporate      operating expenses |                                      | $      | 16,840 |   |   | $ | 17,984 |   |   | $ | 18,500 |   |

----

|                                                           |   | April      30, |    |
|----------------------------------------------------------------|--------|----------------|---------|
| In      thousands except ratio amounts                         |   | 2009           |    |   | 2008 |   |
| Cash      and cash equivalents                                 |   | $              | 10,313  |   |   | $ | 13,892 |   |
| Working      capital                                           |   | $              | 92,839  |   |   | $ | 106,005 |   |
| Total      debt                                                |   | $              | 73,500  |   |   | $ | 42,000 |   |
| Net      debt (total debt less cash and cash equivalents) |   | $              | 63,187  |   |   | $ | 28,108 |   |
| Shareholders'      equity                                      |   | $              | 148,302 |   |   | $ | 169,563 |   |
| Total      capital (net debt plus shareholders' equity)        |   | $              | 211,489 |   |   | $ | 197,671 |   |
| Current      ratio                                             |   | 2.02:1         |    |   | 1.89:1 |   |
| Net      debt-to-total capital ratio                           |   |           | 29.9    | % |   |   | 14.2 | % |

----

|                                           | For      the Fiscal Years Ended April 30, |   |
|------------------------------------------------|-------------------------------------------|--------|
| In      thousands                              |                                      |   | 2009 |   |   |   | 2008 |   |   | 2007 |   |
| Net      cash provided by operating activities |                                      | $      | 9,774 |   |   | $ | 10,205 |   | $ | 272 |   |
| Net      cash used for investing activities    |                                      | $      | (40,418 | ) |   | $ | (13,764 | ) | $ | (5,901 | ) |
| Net      cash provided by financing activities |                                      | $      | 30,139 |   |   | $ | 7,986 |   | $ | 117 |   |

----

| Total      Funded Debt to Consolidated EBITDA Ratio |   | ABR      Margin(basis      points) |   |   | LIBOR      Margin(basis      points) |   |   | Commitment      Fee (basis points) |   |
|-----------------------------------------------------|--------|------------------------------------|--------|--------|--------------------------------------|--------|--------|------------------------------------|--------|
| 3.00x      and greater                              |   |                               | 300.0  |   |                                 |   | 400.0  |                               |   |   | 50.0 |   |
| 2.25x      to less than 3.00x                       |   |                               | 225.0  |   |                                 |   | 325.0  |                               |   |   | 50.0 |   |
| 1.50x      to less than 2.25x                       |   |                               | 175.0  |   |                                 |   | 275.0  |                               |   |   | 37.5 |   |
| 0.75x      to less than 1.50x                       |   |                               | 137.5  |   |                                 |   | 237.5  |                               |   |   | 25.0 |   |
| Less      than 0.75x                                |   |                               | 100.0  |   |                                 |   | 200.0  |                               |   |   | 25.0 |   |

----

| Covenant                                                | Requirement                | Actual      as of April 30, 2009 |
|---------------------------------------------------------|----------------------------|----------------------------------|
| Total      Funded Debt to Consolidated EBITDA           | Less      than 3.75:1.0    | 3.69:1.0                         |
| Consolidated      EBIT to Consolidated Interest Expense | Greater      than 2.75:1.0 | 3.05:1.0                         |
| Asset      Coverage Ratio                               | At      least 1.0:1.0      | 1.2:1.0                          |

----

|                                             |   | Payments      Due by Period |    |
|--------------------------------------------------|--------|-----------------------------|---------|
| In      thousands                                |   | Total                       |    | Less      Than1      Year |   | 1-3      Years |   | 3-5      Years |   | More      than5      Years |   |
| Long-term      debt obligations                  |   | $                           | 73,500  | * |   | $ | --- |   |   | $ | 67,500 | * |   | $ | --- |   |   | $ | 6,000 | * |
| Lease      obligations                           |   |                        | 59,411  |   |   |   | 11,699 |   |   |   | 17,045 |   |   |   | 12,218 |   |   |   | 18,449 |   |
| Inventory      and other purchase obligations    |   |                        | 26,728  |   |   |   | 22,901 |   |   |   | 3,827 |   |   |   | --- |   |   |   | --- |   |
| Qualified      and non-qualified pension funding |   |                        | 5,875   |   |   |   | 586 |   |   |   | 1,163 |   |   |   | 1,163 |   |   |   | 2,963 |   |
| Total                                            |   | $                           | 165,514 |   |   | $ | 35,186 |   |   | $ | 89,535 |   |   | $ | 13,381 |   |   | $ | 27,412 |   |

----

----

----

ITEM

ITEM

ITEM 9

----

ITEM

ITEM

| ·   | proceedings      initiated voluntarily by the director and not by way of defense, except      for claims brought to enforce a right under the indemnification agreement      or claims made with the approval of the Board of Directors; |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | proceedings      by or in right of Gerber, except for the payment of reasonable expenses      incurred if it is determined that the director met the applicable standard      of conduct under Connecticut law; |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | proceedings      with respect to conduct for which the director was adjudged liable on the      basis that the director received a financial benefit to which the director      was not entitled; |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | liability      expressly excluded under Article Seventh, Section 1 of Gerber’s      certificate of incorporation, as it may be amended from time to time;      or    |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | any      claim for expenses or the payment of profits arising out of the director’s      purchase and sale of securities in violation of Section 16(b) of the      Securities Exchange Act of1934. |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

ITEM

----

----

ITEM 

|   | • | establishing      a total compensation philosophy and policies that fairly reward Gerber’s      executive officers for performance benefiting shareholders and that      effectively attract and retain the executive resources necessary to manage      Gerber; |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | assessing      the competitiveness of each element of compensation paid to Gerber’s      executive officers; |
|--------|---------|--------------------------------------------------------------------------------------------------------------------|

|   | • | reviewing      and approving the goals and objectives relevant to compensation of the      Chief Executive Officer, or “CEO,” evaluating the performance of the CEO      based on those goals and objectives, and approving the CEO’s compensation      based on this evaluation; |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | reviewing      the CEO’s evaluation of the performance of Gerber’s other executive      officers based on the objectives established and approved by the      Committee, and reviewing and approving the compensation of the other      executive officers, taking into consideration, among other things, the      recommendations of the CEO; |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | administering      Gerber’s equity compensation plans, including approving equity incentive      guidelines, the general size of overall grants, and specific grants to      Gerber’s executive officers and other  employees; and |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | reviewing      succession plans relating to Gerber’s executive officers, including      candidate readiness, management development initiatives and the need for      external talent acquisition. |
|--------|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

| Name(1)                                                                                                                                                   |   | FeesEarned      orPaid      inCash($) |    |   | StockAwards($)(2) |   |   | OptionAwards($)(3) |   |   | Non-EquityIncentive      PlanCompensation ($) |   |   | Change      in Pension Value and Nonqualified Deferred Compensation Earnings      ($) |    |   | All      OtherCompensation ($) |   |    | Total      ($) |   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------------------------------|---------|--------|-------------------|--------|--------|--------------------|--------|--------|-----------------------------------------------|--------|--------|---------------------------------------------------------------------------------------|---------|--------|--------------------------------|--------|---------|----------------|--------|
| Donald      P. Aiken                                                                                                                                      |   |                                  | 211,000 |   |              |   | 35,025 |               |   |   | —                                       |   |   |                                                                                  | — |   |                           |   | — |           |   |   | — |   |   |   | 246,025 |   |
| Chairman                                                                                                                                                  |   |                                  |    |   |              |   |   |               |   |   |                                          |   |   |                                                                                  |    |   |                           |   |    |           |   |   |   |   |   |   |   |   |
| W.      Jerry Vereen                                                                                                                                      |   |                                  | 80,500  |   |              |   | 35,025 |               |   |   | —                                       |   |   |                                                                                  | — |   |                           |   | — |           |   |   | — |   |   |   | 115,525 |   |
| Member      of Audit and Finance Committee, Nominating and Corporate Governance      Committee and Management Development and Compensation      Committee |   |                                  |    |   |              |   |   |               |   |   |                                          |   |   |                                                                                  |    |   |                           |   |    |           |   |   |   |   |   |   |   |   |
| Carole      F. St. Mark                                                                                                                                   |   |                                  | 76,000  |   |              |   | 35,025 |               |   |   | —                                       |   |   |                                                                                  | — |   |                           |   | — |           |   |   | — |   |   |   | 111,025 |   |
| Chair      of Nominating and Corporate Governance Committee and Member of Management      Development and Compensation Committee                          |   |                                  |    |   |              |   |   |               |   |   |                                          |   |   |                                                                                  |    |   |                           |   |    |           |   |   |   |   |   |   |   |   |
| Edward      G. Jepsen                                                                                                                                     |   |                                  | 87,250  |   |              |   | 35,025 |               |   |   | —                                       |   |   |                                                                                  | — |   |                           |   | — |           |   |   | — |   |   |   | 122,275 |   |
| Chair      of Audit and Finance Committee and Member of Management Development and      Compensation Committee                                            |   |                                  |    |   |              |   |   |               |   |   |                                          |   |   |                                                                                  |    |   |                           |   |    |           |   |   |   |   |   |   |   |   |
| John      R. Lord                                                                                                                                         |   |                                  | 86,500  |   |              |   | 35,025 |               |   |   | —                                       |   |   |                                                                                  | — |   |                           |   | — |           |   |   | — |   |   |   | 121,525 |   |
| Chair      of Management Development and Compensation Committee and Member of Audit      and Finance Committee                                            |   |                                  |    |   |              |   |   |               |   |   |                                          |   |   |                                                                                  |    |   |                           |   |    |           |   |   |   |   |   |   |   |   |
| Randall      D. Ledford                                                                                                                                   |   |                                  | 68,500  |   |              |   | 35,025 |               |   |   | —                                       |   |   |                                                                                  | — |   |                           |   | — |           |   |   | — |   |   |   | 103,525 |   |
| Member      of Nominating and Corporate Governance Committee and Audit and Finance      Committee                                                         |   |                                  |    |   |              |   |   |               |   |   |                                          |   |   |                                                                                  |    |   |                           |   |    |           |   |   |   |   |   |   |   |   |

| (1) | Mr. Giles      is the only Director who is an employee of Gerber. Mr. Giles does not      receive any compensation for his service on the Board.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Amounts      represent the dollar amount recognized for financial statement reporting      purposes for each non-employee Director in fiscal 2009 as computed in      accordance with Statement of Financial Accounting Standards      No. 123(R), Share-Based Payment, or      "SFAS 123R."  Because shares issued to the non-employee      Directors are fully vested at grant, the amount shown represents the full      grant date fair value of each annual fee award of $35,025 computed in      accordance with SFAS 123R. For the assumptions relating to this      valuation, see Note 11 of the Notes to Consolidated Financial      Statements in Item 15 of this Annual Report on Form  10-K. |
| (3) | As      stated in the narrative preceding the table, all grants of common stock to      the non-employee Directors are fully vested upon grant. Under the 1992      Non-Employee Director Stock Option Plan, which expired in August 2002, the      following Directors continue to hold unexercised stock options, all of      which were fully vested as of April 30,  2009:                                                                                                                                                                                                                                                                                                                                                     |

| Director                |   | Options (#) |   |
|-------------------------|--------|------------------|--------|
| Donald      P. Aiken    |   |             | 9,000  |   |
| W.      Jerry Vereen    |   |             | 9,000  |   |
| Carole      F. St. Mark |   |             | 9,000  |   |

----

| §   | each      executive’s performance; |
|--------------------|------------------------------------------|

| §   | each      executive’s current total compensation level relative to peer      companies; |
|--------------------|-----------------------------------------------------------------------------------------------|

| §   | Gerber’s      ability to afford the total compensation  package; |
|--------------------|------------------------------------------------------------------------|

| §   | the      desire to link pay and performance;and |
|--------------------|-------------------------------------------------|

| §   | the      relative pay among our executives. |
|--------------------|---------------------------------------------|

|   | • | confirm      Gerber’s historical practice of linking incentive compensation with      results measured at the company and |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------|

|   | business      unit levels; |
|--------|----------------------------|

|   | • | tighten      the existing severance and change in control agreements and thus also      construct a model agreement for future  use; and |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------|

----

| 3D      Systems Corporation             | ESCO      Technologies, Inc.     | Newport      Corporation               |
|-----------------------------------------|----------------------------------|----------------------------------------|
|                                    |                             |                                   |
| Applied      Materials, Inc.       | Esterline      Technologies Co.  | Parametric      Technology Corporation |
|                                    |                             |                                   |
| Brooks      Automation, Inc.       | Excel      Technology, Inc.      | Rofin-Sinar      Technologies, Inc.    |
|                                    |                             |                                   |
| Cadence      Design Systems, Inc.  | GSI      Group, Inc.             | Roper      Industries, Inc.            |
|                                    |                             |                                   |
| Coherent,      Inc.                | KLA-Tencor      Corporation      | Stratasys,      Inc.                   |
|                                    |                             |                                   |
| Cymer,      Inc.                   | Mentor      Graphics Corporation | Tektronix,      Inc.                   |
|                                    |                             |                                   |
| Electroglas,      Inc.             | MKS      Instruments, Inc.       | Veeco      Instruments, Inc.           |

----

|   | • | individual      performance, which we measure in consultation with Mr. Giles (except      when assessing Mr. Giles’s own  performance); |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | grants      of long-term equity compensation, composed of stock options which vest      over a three-year period and restricted stock which vests over a four-year      period; |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | a      defined benefit retirement pension plan and a 401(k) plan available to all      of our employees, including the named executive officers, on an equal      basis, as well as, for our more highly paid employees (including the named      executive officers), a supplemental employment retirement plan, or      “SERP”; and |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | competitive      severance and change in control agreements for the named executive      officers and some other seniorexecutives. |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------|

----

|   | • | Mr. Giles,      our CEO, was given a 5.3% base salary increase, from $570,000 to $600,000,      based on the overall strong performance in leading the company,      particularly with regard to placing Gerber on a stronger financial footing      and reinvigorating the new product development process. The Committee      believes that the base salary for Mr. Giles, relative to our other      executive officers, is appropriate given his level of responsibility      within the company and the fact that his base salary is comparable on a      relative basis with CEO base salaries paid by our peer      companies. |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Mr.      Elia, our CFO, joined the company at the very end of fiscal 2008 and      therefore was not eligible for a salary increase based on fiscal 2008      performance. His salary remained at$350,000. |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | The      Committee approved a base salary increase of 10.3% for Mr. Hancock,      who took on the additional responsibility of managing the shared Customer      Service organization. Mr. Larson received an increase of 6.3% based on      strong Spandex performance. Mr. Lovass received a 10.9% increase, based on      his transfer to a larger business unit as  President. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | • | Mr. Giles,      75% (with a minimum of 0% and a maximum of 150% of base      salary); |
|--------|---------|--------------------------------------------------------------------------------------------|

|   | • | Mr.      Elia, 60% (with a minimum of 0% and a maximum of 120% of base      salary); |
|--------|---------|--------------------------------------------------------------------------------------|

|   | • | Mr. Lovass,      50% (with a minimum of 0% and a maximum of 100% of base      salary); |
|--------|---------|---------------------------------------------------------------------------------------------|

|   | • | Mr. Hancock,      50% (with a minimum of 0% and a maximum of 100% of base salary);      and |
|--------|---------|--------------------------------------------------------------------------------------------------|

|   | • | Mr. Larson,      50% (with a minimum of 0% and a maximum of 100% of base      salary). |
|--------|---------|---------------------------------------------------------------------------------------------|

|   | • | his      target payout (expressed as a percentage of base  salary); |
|--------|---------|---------------------------------------------------------------------|

|   | • | the      cumulative performance results for fiscal2009; |
|--------|---------|---------------------------------------------------------|

|   | • | the      percentage of the executive’s bonusearned; |
|--------|---------|-----------------------------------------------------------|

|   | • | the      executive’s end-of-year base salary (reflecting the annual salary      increases during fiscal 2009); and |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------|

|   | • | the      actual bonus payout. |
|--------|---------|-------------------------------|

| Name             |   | Target      % |   |   | Bonus      % |   |   | %      Earned |   |   | Base      $ |   |   | $      Earned |    |
|------------------|--------|---------------|--------|--------|--------------|--------|--------|---------------|--------|--------|-------------|--------|--------|---------------|---------|
|             |   |          |   |   |         |   |   |          |   |   |        |   |   |          |    |
| Mr.      Giles   |   |          | 75     |   |         |   | ---    |          |   |   | ---         |   |   |          | 600,000 |   |   |   | --- |   |
| Mr.      Elia    |   |          | 60     |   |         |   | ---    |          |   |   | ---         |   |   |          | 350,000 |   |   |   | --- |   |
| Mr.      Lovass  |   |          | 50     |   |         |   | ---    |          |   |   | ---         |   |   |          | 255,000 |   |   |   | --- |   |
| Mr.      Larson  |   |          | 50     |   |         |   | ---    |          |   |   | ---         |   |   |          | 255,000 |   |   |   | --- |   |
| Mr.      Hancock |   |          | 50     |   |         |   | ---    |          |   |   | ---         |   |   |          | 285,000 |   |   |   | --- |   |

----

----

----

----

| Name      and Principal Position                                      | FiscalYear |   | Salary      ($)(1) |    |   | Bonus($) |   |    | StockAwards($)(2) |   |   | Option      Awards($)(3) |   |   | Non-EquityIncentive      PlanCompensation ($)(4) |    |   | Change      inPension Value and Nonqualified Deferred Compensation      Earnings($)(5) |   |    | All      OtherCompensation ($)(6) |   |   | Total      ($) |   |
|-----------------------------------------------------------------------|------------|--------|--------------------|---------|--------|----------|--------|---------|-------------------|--------|--------|--------------------------|--------|--------|--------------------------------------------------|---------|--------|----------------------------------------------------------------------------------------|--------|---------|-----------------------------------|--------|--------|----------------|--------|
| Marc      T. Giles                                                    | 2007       |   |               | 528,731 |   |     |   | — |              |   |   | 22,585                   |   |   |                                             | 193,454 |   |                                                                                   |   | 282,038 |                              |   |   | 75,106         |   |   |   | 4,000 |   |   |   | 1,105,914 |   |
| President      and Chief                                              | 2008       |   |               | 561,346 |   |     |   | — |              |   |   | 86,877                   |   |   |                                             | 328,980 |   |                                                                                   |   | 288,563 |                              |   |   | 72,500         |   |   |   | 4,000 |   |   |   | 1,342,266 |   |
| Executive      Officer                                                | 2009       |   |               | 544,038 |   |     |   | — |              |   |   | 172,080                  |   |   |                                             | 568,373 |   |                                                                                   |   | — |                              |   |   | 37,600         |   |   |   | — |   |   |   | 1,322,091 |   |
| Michael      R. Elia                                                  | 2007       |   |               | — |   |     |   | — |              |   |   | —                  |   |   |                                             | — |   |                                                                                   |   | — |                              |   |   | —        |   |   |   | — |   |   |   | — |   |
| Executive      Vice President and Chief                               | 2008       |   |               | 5,385   |   |     |   | 50,000  | (7)               |   |   | 7,022                    |   |   |                                             | 17,615  |   |                                                                                   |   | — |                              |   |   | —        |   |   |   | 194 |   |   |   | 80,216 |   |
| Financial      Officer                                                | 2009       |   |               | 330,481 |   |     |   | — |              |   |   | 111,175                  |   |   |                                             | 264,000 |   |                                                                                   |   | — |                              |   |   | —        |   |   |   | 3,806 |   |   |   | 709,462 |   |
| Stephen      Lovass.                                                  | 2007       |   |               | 203,192 |   |     |   | — |              |   |   | —                  |   |   |                                             | 117,750 |   |                                                                                   |   | 59,450  |                              |   |   | 9,343          |   |   |   | 104,725 |   |   |   | 494,460 |   |
| Senior      Vice President,                                           | 2008       |   |               | 229,999 |   |     |   | — |              |   |   | 20,803                   |   |   |                                             | 67,516  |   |                                                                                   |   | 81,988  |                              |   |   | 8,200          |   |   |   | 64,241 |   |   |   | 472,747 |   |
| Gerber      Scientific, Inc. and President Gerber Scientific Products | 2009       |   |               | 240,778 |   |     |   | — |              |   |   | 63,909                   |   |   |                                             | 145,044 |   |                                                                                   |   | — |                              |   |   | 4,100          |   |   |   | 109,221 |   |   |   | 563,052 |   |
| Rodney      Larson                                                    | 2007       |   |               | — |   |     |   | — |              |   |   | —                  |   |   |                                             | — |   |                                                                                   |   | — |                              |   |   | —        |   |   |   | — |   |   |   | — |   |
| Senior      Vice President,                                           | 2008       |   |               | 234,462 |   |     |   | — |              |   |   | 15,580                   |   |   |                                             | 25,926  |   |                                                                                   |   | 104,050 |                              |   |   | —        |   |   |   | 207,523 |   |   |   | 587,541 |   |
| Gerber      Scientific, Inc. and President, Spandex                   | 2009       |   |               | 235,010 |   |     |   | — |              |   |   | 44,452                   |   |   |                                             | 78,173  |   |                                                                                   |   | — |                              |   |   | —        |   |   |   | 263,359 |   |   |   | 639,851 |   |
| John      Hancock                                                     | 2007       |   |               | 241,748 |   |     |   | — |              |   |   | —                  |   |   |                                             | 72,634  |   |                                                                                   |   | 73,402  |                              |   |   | 54,006         |   |   |   | 3,095 |   |   |   | 444,885 |   |
| Senior      Vice President,                                           | 2008       |   |               | 254,897 |   |     |   | 25,834  | (8)               |   |   | 6,581                    |   |   |                                             | 112,575 |   |                                                                                   |   | 72,076  |                              |   |   | 56,800         |   |   |   | 4,124 |   |   |   | 532,887 |   |
| Gerber      Scientific, Inc. and President, Gerber Technology         | 2009       |   |               | 258,850 |   |     |   | — |              |   |   | 90,343                   |   |   |                                             | 106,233 |   |                                                                                   |   | — |                              |   |   | 41,100         |   |   |   | 781 |   |   |   | 497,307 |   |

| (1) | Salary      includes compensation used for medical insurance premiums and      contributions to Gerber's 401(k) savings and medical plans, which is not      taxable income.                                                                                                                                                                                                                                                                 |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Amounts      represent the dollar amounts recognized for financial statement reporting      purposes during fiscal 2009, fiscal 2008 and fiscal 2007, respectively, as      required by SFAS 123R, disregarding any estimate of forfeitures      relating to service-based vesting conditions.                                                                                                                                          |
| (3) | Amounts      represent the dollar amounts recognized for financial statement reporting      purposes for each named executive officer during fiscal 2009, fiscal 2008      and fiscal 2007, respectively, as required by SFAS 123R, disregarding      any estimates of forfeitures relating to service-based vesting conditions.      The weighted-average assumptions used in valuing the amounts set forth      above are as follows: |

----

|                         | For the Fiscal Years Ended      April 30,                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                         |                            2009 | 2008                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 2007 | 2006 | 2005 |   |
| Expected      option term    | 5.5      years                                                                                                                           | 5.9 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 5.0 years | 5.7 years | 4.7 years |   |
| Expected      volatility     | 46%                                                                                                                                      | 51%                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 55% | 73% | 74% |   |
| Risk-free      interest rate | 3.0%                                                                                                                                     | 3.2%                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 4.5% | 4.4% | 3.8% |   |
|                         | (4)                                                                                                                                      | Amounts      represent the actual amounts paid to each named executive officer pursuant      to Gerber's fiscal 2009, fiscal 2008 and fiscal 2007 annual incentive      compensation plans, respectively. For fiscal 2009, Gerber did not reach      its performance goals, and paid no bonuses to the named executive      officers.  See the “Fiscal 2009 Grants of Plan-Based Awards”      table immediately below and “2009 Annual Incentive Compensation Plan”      under “Compensation Discussion and Analysis–Elements of Our Executive      Compensation Program” above for additional information about our fiscal      2009 annual incentive compensation plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                         | (5)                                                                                                                                      | Amounts      represent solely the change in pension value and include both Gerber’s      qualified pension plan and its nonqualified supplemental employee      retirement plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                         | (6)                                                                                                                                      | “All      Other Compensation” for fiscal 2009 represents (a) for      Mr. Giles, Gerber’s matching contribution to the company’s 401(k)      plan, which for calendar years 2007 and 2008 was a maximum of $4,000 under      the matching formula which applies to all participants in the 401(k) plan,      and for calendar year 2009 was $0 because the company’s matching      contribution was suspended prior to any contributions to the plan;      (b) for Mr. Elia, Gerber’s matching contribution to the      company’s 401(k) plan; (c) for Mr. Lovass, Gerber’s matching      contribution to the company’s 401(k) plan of $961, foreign tax payments on      his behalf calculated and paid during fiscal 2009 for past assignment in      Belgium of $104,521, tax equalization of $1,240 and foreign tax      preparation service of $2,500; (d) for Mr. Larson, an expatriate      living allowance of $19,027, family tuition fees for the school year of      $124,999, a car lease in the amount of $15,842, foreign tax payments on      his behalf calculated and paid during fiscal 2009 for current assignment      in Belgium of $62,852, tax equalization of $3,939 and foreign tax      preparation service of $2,500, and Gerber’s matching contribution of      $1,009 to the company’s 401(k) plan; and (f) for Mr. Hancock,      the company’s matching contribution to the company’s 401(k)      plan. |
|                         | (7)                                                                                                                                      | Amount      represents a signing bonus paid to Mr. Elia upon commencement of      employment on April 15, 2008.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                         | (8)                                                                                                                                      | Amount      represents a special incentive bonus for business unit presidents to      reduce inventory during the latter part of fiscal  2008.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

----

|                 |   |    |   |   |                                                                     |    |    | All      Other                                      |   |    | All      Other                               |   |   |                                 |    |   |                                |   |
|----------------------|--------|---------|--------|--------|--------------------------------------------------------------------------|---------|---------|-----------------------------------------------------|--------|---------|----------------------------------------------|--------|--------|--------------------------------------|---------|--------|-------------------------------------|--------|
|                 |   |    |   |   |                                                                     |    |    | Stock                                               |   |    | Option                                       |   |   |                                 |    |   | Grant      Date                     |   |
|                 |   |    |   |   | Estimated      Possible Payouts Under Non-Equity Incentive PlanAwards(1) |    |    | Awards: No.      ofShares      ofStock      or |   |    | Awards: No.      ofSecuritiesUnderlying |   |   | Exercise      or Base Price ofOption |    |   | Fair      Value of Stock and Option |   |
|                 |   | Grant   |   |   | Threshold                                                                |    |    | Target                                              |   |    | Maximum                                      |   |   | Units                                |    |   | Options                             |   |   | Awards |   |   | Awards |   |
| Name                 |   | Date    |   |   | ($)                                                                      |    |    | ($)                                                 |   |    | ($)                                          |   |   |                                 | (#      | )(2)   |                                |   | (# | )(3) |   | ($/Sh) |   |   | ($) |   |
| Marc      T. Giles   |   |    | (1     | )      |                                                                     |    | — |                                                |   |    | 450,000                                      |   |   |                                 | 900,000 |   |                                |   | — |   |   |   | — |   |   |   | — |   |   |   | — |   |
|                 |   | 9/25/08 |   |   |                                                                     | — |    |                                                |   | — |                                         |   |   | —                              |    |   |                                | 30,000 |   |   |   | 138,000 |   |   |   | 8.99 |   |   |   | 802,311 |   |
| Michael      R. Elia |   |    | (1     | )      |                                                                     |    | — |                                                |   |    | 210,000                                      |   |   |                                 | 420,000 |   |                                |   | — |   |   |   | — |   |   |   | — |   |   |   | — |   |
|                 |   | 9/25/08 |   |   |                                                                     | — |    |                                                |   | — |                                         |   |   | —                              |    |   |                                | 15,000 |   |   |   | 45,000 |   |   |   | 8.99 |   |   |   | 308,528 |   |
| Stephen      Lovass  |   |    | (1     | )      |                                                                     |    | — |                                                |   |    | 127,500                                      |   |   |                                 | 255,000 |   |                                |   | — |   |   |   | — |   |   |   | — |   |   |   | — |   |
|                 |   | 9/25/08 |   |   |                                                                     | — |    |                                                |   | — |                                         |   |   | —                              |    |   |                                | 7,500  |   |   |   | 22,500 |   |   |   | 8.99 |   |   |   | 154,264 |   |
| Rodney      Larson   |   |    | (1     | )      |                                                                     |    | — |                                                |   |    | 127,500                                      |   |   |                                 | 255,000 |   |                                |   | — |   |   |   | — |   |   |   | — |   |   |   | — |   |
|                 |   | 9/25/08 |   |   |                                                                     | — |    |                                                |   | — |                                         |   |   | —                              |    |   |                                | 9,400  |   |   |   | 28,200 |   |   |   | 8.99 |   |   |   | 193,344 |   |
| John      Hancock    |   |    | (1     | )      |                                                                     |    | — |                                                |   |    | 142,500                                      |   |   |                                 | 285,000 |   |                                |   | — |   |   |   | — |   |   |   | — |   |   |   | — |   |
|                 |   | 9/25/08 |   |   |                                                                     | — |    |                                                |   | — |                                         |   |   | —                              |    |   |                                | 36,900 |   |   |   | — |   |   |   | 8.99 |   |   |   | 331,731 |   |

| (1) | Amounts      represent the potential amounts to be earned under the fiscal 2009 annual      incentive compensation plan. For a discussion of the performance metrics      applicable to these awards, see “2009 Annual Incentive Compensation Plan”      under “Compensation Discussion and Analysis-Elements of Our Executive      Compensation Program” above. For the actual amounts earned by each named      executive officer, see the “Non-Equity Incentive Plan Compensation” column      of the “Fiscal 2009 Summary Compensation Table” above. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Represents      awards of restricted stock under the 2006 Omnibus Incentive      Plan.  Restricted stock awards generally vest ratably over four      years on each anniversary of the grant date, with the exception of the      grant to Mr. Hancock, which vests ratably over three years on each      anniversary of the grant date                                                                                                                                                                                                                                                   |
| (3) | Represents      awards of stock options under the 2006 Omnibus Incentive      Plan.  Stock option awards vest ratably over three years on each      anniversary of the grant date.                                                                                                                                                                                                                                                                                                                                                                                                             |

----

|                                                            |          | Option      Awards | Stock      Awards |
|-----------------------------------------------------------------|---------------|--------------------|-------------------|
|                                                            |          | Number      of     | Number      of    |   |   | Number      of | Market      Value |
|                                                            |          | Securities         | Securities        |   |   | Shares      or | of      Shares |
|                                                            |          | Underlying         | Underlying        |   |   | Units      of | or      Units of |
|                                                            |          | Unexercised        | Unexercised       | Option | Option | Stock      That | Stock      That |
|                                                            | Grant         | Options      (#)   | Options      (#)  | Exercise | Expiration | Have      Not | Have      Not |
| Name                                                            | Date          | Exercisable        | Unexercisable     | Price ($) | Date | Vested (#) | Vested      ($)(1) |
| Marc      T. Giles                                              | 12/4/2000(2)  | 50,000             | —           | 7.06 | 12/4/2010 | — | — |
| President      and Chief                                        | 12/5/2006(2)  | 33,333             | 16,667            | 13.97 | 12/5/2016 | 8,000 | 31,600 |
| Executive Officer                                               | 12/22/2006(3) | —            | 41,515            | 12.69 | 12/6/2011 | — | — |
|                                                            | 3/16/2007(4)  | —            | 33,300            | 9.89 | 6/18/2012 | — | — |
|                                                            | 12/1/2007(2)  | 38,333             | 76,667            | 9.50 | 11/30/2017 | 22,500 | 88,875 |
|                                                            | 9/25/2008(2)  | —            | 138,000           | 8.99 | 9/25/2018 | 30,000 | 118,500 |
| Total                                                           |          | 121,666            | 306,149           |   |   | 60,500 | 238,975 |
| Michael      R. Elia                                            | 4/15/2008(5)  | —            | 100,000           | 8.87 | 4/14/2018 | 20,000 | 79,000 |
|  Executive      Vice President and Chief Financial Officer | 9/25/2008(2)  | —            | 45,000            | 8.99 | 9/25/2018 | 15,000 | 59,250 |
| Total                                                           |          | —            | 145,000           |   |   | 35,000 | 138,250 |
| Stephen      Lovass                                             | 7/1/2004(2)   | 5,000              | —           | 6.85 | 7/1/2014 | — | — |
| Senior Vice President,                                          | 12/6/2005(2)  | 15,000             | —           | 9.45 | 12/6/2015 | — | — |
| Gerber Scientific, Inc.,                                        | 12/5/2006(2)  | 10,000             | 5,000             | 13.97 | 12/5/2016 | — | — |
| and      President Gerber                                       | 6/19/2007(2)  | —            | —           | — | — | 2,625 | 10,369 |
| Scientific      Products                                        | 12/1/2007(2)  | 6,667              | 13,333            | 9.50 | 11/30/2017 | 5,250 | 20,737 |
|                                                            | 3/7/2008(6)   | —            | 20,000            | 7.91 | 3/7/2018 | 7,000 | 27,650 |
|                                                            | 9/25/2008(2)  | —            | 22,500            | 8.99 | 9/25/2018 | 7,500 | 29,625 |
| Total                                                           |          | 36,667             | 60,833            |   |   | 22,375 | 88,381 |
| Rodney      Larson                                              | 6/19/2007(2)  | 1,667              | 3,333             | 11.99 | 6/19/2017 | 2,250 | 8,888 |
| Senior      Vice                                                | 12/1/2007(2)  | 8,333              | 16,667            | 9.50 | 11/30/2017 | 6,750 | 26,662 |
| President,      Gerber Scientific, Inc. and President, Spandex  | 9/25/2008(2)  | —            | 28,200            | 8.99 | 9/25/2018 | 9,400 | 37,130 |
| Total                                                           |          | 10,000             | 48,200            |  |   | 18,400 | 72,680 |
| John      Hancock                                          | 5/1/2000(2)   | 6,500              | —           | 13.62 | 5/1/2010 | — | — |
|  Senior      Vice                                          | 5/4/2001(2)   | 5,525              | —           | 7.20 | 5/4/2011 | — | — |
|  President,      Gerber                                    | 12/7/2001(2)  | 20,000             | —           | 9.34 | 12/7/2011 | — | — |
|  Scientific,      Inc. and                                 | 6/18/2002(2)  | 20,000             | —           | 3.35 | 6/18/2012 | — | — |
|  President, Gerber                                         | 8/2/2004(2)   | 15,000             | —           | 6.28 | 8/2/2014 | — | — |
| Technology,      Inc.                                           | 12/6/2005(2)  | 20,000             | —           | 9.45 | 12/6/2015 | — | — |
|                                                            | 12/05/2006(2) | 13,333             | 6,667             | 13.97 | 12/5/2016 | — | — |
|                                                            | 12/1/2007(2)  | 6,667              | 13,333            | 9.50 | 11/30/2017 | 5,250 | 20,738 |
|                                                            | 9/25/2008(2)  | —            | —           | — | — | 36,900 | 145,755 |
| Total                                                           |               | 107,025            | 20,000            |  |  | 42,150 | 166,493 |

| (1) | Valuation      is based on the $3.95 closing price of Gerber’s common stock on      April 30, 2009 as reported on the NYSE.                                                                                                                                                                                                                                                                                                                                           |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Stock      options granted on these dates generally vest ratably over a three-year      period, beginning on the first anniversary of the grant date. Restricted      stock granted on these dates vest ratably over a four-year period,      beginning on the first anniversary of the grant date, with the exception      of the 9/25/2008 grant to Mr. Hancock, which vests ratably over a      three-year period, beginning on the first anniversary of the grant      date. |
| (3) | This      stock option represents a reload stock option granted to Mr. Giles on      December 22, 2006 upon his exercise of the original option. This      option will vest in full on December 22, 2009, assuming      Mr. Giles continues to hold the shares of common stock he received      upon exercise of the original option for the full three-year vesting      requirement.                                                                       |
| (4) | This      stock option represents a reload stock option granted to Mr. Giles on      March 16, 2007 upon his exercise of the original option. This option      will vest in full on March 16, 2010, assuming Mr. Giles      continues to hold the shares of common stock he received upon exercise of      the original option for the full three-year vesting      requirement.                                                                             |
| (5) | Mr. Elia’s      April 25, 2008 stock option and restricted stock grants vest on      April 15, 2010.                                                                                                                                                                                                                                                                                                                                                             |
| (6) | Mr. Lovass’s      March 7, 2008 stock option and restricted stock grants vest on May 2,      2010.                                                                                                                                                                                                                                                                                                                                                                    |

----

|                 |   | Option      Awards                                       |    |   | Stock      Awards                     |   |
|----------------------|--------|----------------------------------------------------------|---------|--------|---------------------------------------|--------|
| Name                 |   | Number of      Shares Acquired on Exercise (#) |    |   | ValueRealized      on Exercise ($)(1) |   |   | Number      of SharesAcquired on Vesting (#) |   |   | Value      Realizedon      Vesting ($)(2) |   |
| Marc      T. Giles   |   |                                                     | 100,000 |   |                                  |   | 471,000 |   |   |   | 11,500 |   |   |   | 24,535 |   |
| Michael      R. Elia |   |                                                     | — |   |                                  |   | — |   |   |   | — |   |   |   | — |   |
| Stephen      Lovass. |   |                                                     | — |   |                                  |   | — |   |   |   | 2,625 |   |   |   | 14,131 |   |
| Rodney      Larson   |   |                                                     | — |   |                                  |   | — |   |   |   | 3,000 |   |   |   | 13,590 |   |
| John      Hancock    |   |                                                     | — |   |                                  |   | — |   |   |   | 1,750 |   |   |   | 3,448 |   |

| (1) | Value      realized is calculated by multiplying the number of shares acquired upon      exercise by the difference between the fair market value of Gerber’s      common stock on the date of exercise minus the exercise price of the stock      option. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Value      realized is calculated by multiplying the number of shares by the closing      price of Gerber’s common stock on the NYSE on the vesting      date.                                                                                             |

----

----

| Fiscal      2009 Pension Benefits Table |                                         |
|-----------------------------------------|----------------------------------------------|
| Name                                    | Plan      Name                               |   | Numberof      YearsCreditedService(1) |   |   | Present      Valueof      AccumulatedBenefit(2) |   |   | Payments      During Last Fiscal Year |   |
| Marc      T. Giles                      | Gerber      Scientific, Inc. and             |   |   | 8.5 |   |   |   |   |   |   |   |
|                                    | Participating      Subsidiaries Pension Plan |   |   |   |   |   | $ | 94,200 |   |   |   | — |   |
|                                    | Gerber      Scientific, Inc. SERP            |   |   |   |   |   | $ | 210,400 |   |   |   | — |   |
|                                    |                                         |   |   |   |   |   |   |   |   |   |   |   |   |
| Stephen      Lovass                     | Gerber      Scientific, Inc. and             |   |   | 8.0 |   |   |   |   |   |   |   |   |   |
|                                    | Participating      Subsidiaries Pension Plan |   |   |   |   |   | $ | 33,100 |   |   |   | — |   |
|                                    | Gerber      Scientific, Inc. SERP            |   |   |   |   |   | $ | 6,400 |   |   |   | — |   |
|                                    |                                         |   |   |   |   |   |   |   |   |   |   |   |   |
| John      Hancock                       | Gerber      Scientific, Inc. and             |   |   | 11.2 |   |   |   |   |   |   |   |   |   |
|                                    | Participating      Subsidiaries Pension Plan |   |   |   |   |   | $ | 225,400 |   |   |   | — |   |
|                                    | Gerber      Scientific, Inc. SERP            |   |   |   |   |   | $ | 83,800 |   |   |   | — |   |

| (1) | Number      of years of credited service is computed as of April 30, 2009. The      number of years of credited service for each named executive officer is      equal to his actual years of service with Gerber as of April 30,      2009. Gerber does not have a policy of granting extra years of credited      service to its named executive officers or other participating employees      generally. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Amounts      represent the present value of the accumulated benefit under the qualified      plan or SERP, as applicable, as of April 30, 2009. For the      assumptions used in determining these amounts, see Note 13 of the      Notes to Consolidated Financial Statements in Item 15 of this Annual      Report on Form 10-K.                                                                           |

|   | • | continuation      of base salary, as in effect as of the termination date, for      (1) 16 months, in the case of Mr. Giles, or      (2) 12 months, in the case of Messrs. Elia, Lovass, Larson      and Hancock, payable in accordance with the company’s normal payroll      practices; |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | the      pro rata portion (through the date of termination) of the target annual      incentive compensation that the officer would have earned if the officer      had continued his employment with the company through the end of the      fiscal year in which the termination occurred, payable at the time such      compensation is normally paid and only if the performance goals relating      to the compensation areachieved; and |
|--------|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | continuation      of company-paid health (medical and dental) insurance coverage for      (1) 16 months, in the case of Mr. Giles, or      (2) 12 months, in the case of Messrs. Elia, Lovass, Larson      and Hancock, and continued life insurance benefits for a period of      30 days followingtermination. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | • | competes      with the business of the company; |
|--------|---------|-------------------------------------------------|

|   | • | discloses      confidential information or data relating to the  company; |
|--------|---------|---------------------------------------------------------------------------|

|   | • | appropriates      any such information or data for his own  benefit; |
|--------|---------|----------------------------------------------------------------------|

|   | • | solicits      or hires any person who is, or has been in the prior six months, employed      by the company to leave thecompany; |
|--------|---------|----------------------------------------------------------------------------------------------------------------------------------|

|   | • | solicits      or diverts the business of any customer or client, or any prospective      customer or client, of the company; |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------|

|   | • | engages      in any action that is determined by the Management Development and      Compensation Committee to be detrimental to the company and its      shareholders; or |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | is      engaged in full-time employment, other than as described above regarding      employment with a company that is not a competitor of the      company. |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | a      lump sum severance payment equal to (1) three times the sum of his      base salary and annual incentive bonus payment in effect as of the      termination date, in the case of Mr. Giles, or (2) 2.5 times the      sum of his base salary and annual incentive bonus payment in effect as of      the termination date, in the case of each of Messrs. Elia, Lovass,      Larson and Hancock; |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | a      lump sum cash payment equal to (1) 36 monthly payments, in the      case of Mr. Giles, or (2) 30 monthly payments, in the case      of each of Messrs. Elia, Lovass, Larson and Hancock, that would have      been paid by the company for the cost of all life insurance, health      (medical and dental), accidental death and dismemberment, and disability      plans in which the executive was entitled to participate immediately prior      to the date oftermination; and |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | acceleration      and full vesting of all unvested stockawards. |
|--------|---------|-----------------------------------------------------------------|

----

|   | • | a      material diminution in the nature and scope of the executive’s authority,      duties or responsibilities from those applicable immediately prior to the      change in control; |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | a      reduction in the executive’s base salary from that provided immediately      prior to the change in control; |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------|

|   | • | a      diminution in the executive’s eligibility to participate in compensation      plans and employee benefits and perquisites which provided opportunities      to receive overall compensation and benefits and perquisites from the      greater of: |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | the      opportunities provided by the company for executives with comparable      duties; or |
|--------|---------|----------------------------------------------------------------------------------------------------|

|   | • | the      opportunities under any such plans and perquisites under which the      executive was participating immediately prior to the change in      control. |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | a      change in the location of the executive’s principal place of employment by      more than 50 miles from the location applicable immediately prior to      the change in control; |
|--------|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | a      significant increase in the executive’s frequency or duration of business      travel; or |
|--------|---------|-------------------------------------------------------------------------------------------------------------|

|   | • | a      reasonable determination by the Board of Directors that, as a result of      the change in control and change in circumstances thereafter significantly      affecting the executive’s position, the executive is unable to exercise      the authority, powers, functions or duties applicable to his position      immediately prior to the change incontrol. |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | the      company merges or consolidates with another entity resulting in less than      50% ownership, or the company sells or otherwise disposes of all or      substantially all of its assets; |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | the      shareholders of the company adopt a plan of  liquidation; |
|--------|---------|--------------------------------------------------------------------|

|   | • | any      person generally becomes the beneficial owner of 30% or more of the      company’s voting securities; or |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------|

|   | • | as      a result of any tender or exchange offer, merger or disposition of all or      substantially all of the company’s assets, the Directors of the company as      of the date of the severance agreements cease to constitute a majority of      the Board of Directors (with exception for Directors subsequently approved      by three-fourths of the Directors as of the date of the severance      agreements). |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | the      entry by the company into an agreement, the consummation of which would      result in the occurrence of a change incontrol; |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------|

|   | • | the      public announcement by any person of an intention to take actions which,      if consummated, would constitute a change in    control; or |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | the      adoption by the Board of Directors of a resolution to the effect that, for      purposes of the severance agreements, a change in control has      occurred. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Named      Executive Officer |   | Severance      Policy($)(1) |    |   | Change      in ControlAgreements($)(2) |   |      | Continuation      of VestingUpon      Retirement($)(3) |   |
|------------------------------|--------|-----------------------------|---------|--------|----------------------------------------|--------|-----------|--------------------------------------------------------|--------|
| Marc      T. Giles           |   |                        | 815,380 |   |                                   |   | 2,527,639 |                                                   |   |   | — |   |
| Michael      R. Elia         |   |                        | 360,625 |   |                                   |   | 1,252,722 |                                                   |   |   | — |   |
| Stephen      Lovass.         |   |                        | 266,492 |   |                                   |   | 884,321   |                                                   |   |   | — |   |
| Rodney      Larson           |   |                        | 266,492 |   |                                   |   | 868,620   |                                                   |   |   | — |   |
| John      Hancock            |   |                        | 296,499 |   |                                   |   | 1,031,932 |                                                   |   |   | — |   |

| (1) | Amounts      calculated based on each executive’s base salary as of April 30,      2009, or $800,000 ($600,000 times 1.33 years) for Mr. Giles, $350,000      for Mr. Elia, $255,000 for Mr. Lovass, $255,000 for Mr. Larson      and $285,000 for Mr. Hancock. Amounts include continuation of health      (medical and dental) and life insurance benefits for the periods described      under “Severance Policy for Senior Executives” above as follows: $15,380      for Mr. Giles; $10,650 for Mr. Elia; $11,492 for      Mr. Lovass; $11,492 for Mr. Larson; and $11,499 for      Mr. Hancock. Amounts do not include any pro rata bonus payments; each      executive’s fiscal 2009 bonus is set forth in the fiscal 2009 “Non-Equity      Incentive Compensation Plan” column of the “Fiscal 2009 Summary      Compensation Table” above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Represents      amounts to be provided pursuant to each executive’s change in control      agreement. Amounts include the following: (a) a lump sum severance      payment, calculated based on each executive’s base salary as of      April 30, 2009, or $1,800,000 ($600,000 times three years) for      Mr. Giles, $875,000 ($350,000 times 2.5 years) for      Mr. Elia, $637,500 ($255,000 times 2.5 years) for      Mr. Lovass, $637,500 ($255,000 times 2.5 years) for      Mr. Larson and $712,500 ($285,000 times 2.5 years) for      Mr. Hancock, and each executive’s target annual incentive bonus      payment for fiscal 2009, or $450,000 for Mr. Giles, $210,00 for Mr.      Elia, $127,500 for Mr. Lovass, $127,500 for Mr. Larson and      $142,500 for Mr. Hancock; (b) a lump sum payment equal to      $38,664 for Mr. Giles, $29,472 for Mr. Elia, $30,940 for      Mr. Lovass, $30,940 for Mr. Larson and $31,177 for      Mr. Hancock, reflecting the amount the company would have paid for      the cost of all life insurance, health (medical and dental), accidental      death and dismemberment and disability plans in which the executive was      entitled to participate as of April 30, 2009; and (c) the      acceleration of all unvested stock option and restricted stock awards held      by each officer as of April 30, 2009, as follows: $238,975 for      Mr. Giles, $138,250 for Mr. Elia, $88,381 for Mr. Lovass,      $72,680 for Mr. Larson and $145,755 for Mr. Hancock. For stock      option awards, amounts calculated are based on the difference between the      option’s exercise price and the fair market value of our common stock on      April 30, 2009, or $3.95 per share, multiplied by the number of      shares. For restricted stock awards, the amount calculated is based on the      number of shares multiplied by the fair market value of our common stock      on April 30, 2009. For purposes of these equity acceleration      estimates, we have not included outstanding unvested out-of-the-money      stock option awards pursuant to which the exercise price of the option      exceeded the fair market value of our common stock on April 30, 2009.      See the “Fiscal 2009 Outstanding Equity Awards at Fiscal Year-End” table      above for information on these awards. |
| (3) | As      discussed above, executives holding outstanding, unvested stock option      awards under our 2003 Employee Stock Option Plan are entitled to two      additional years of vesting upon retirement. As of April 30, 2009,      however, unvested stock options outstanding under this plan were      out-of-the-money options because the exercise price of the options      exceeded the fair market value of our common stock on April 30, 2009,      or $3.95 per share.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

----

ITEM

| Name      and Address of Beneficial Owner |   | Amount      and Nature ofBeneficial      Ownership |      |   | Percent      ofClass (%) |   |
|-------------------------------------------|--------|----------------------------------------------------|-----------|--------|-------------------------------|--------|
| Mario      J. Gabelli and affiliates      |   |                                               | 2,247,263 |   |                          |   | 9.13 |   |
| One      Corporate Center                 |   |                                               |      |   |                          |   |   |   |
| Rye,      New York 10580                  |   |                                               |      |   |                          |   |   |   |
| Zesiger      Capital Group LLC            |   |                                               | 2,051,400 |   |                          |   | 8.33 |   |
| 320      Park Ave. 30th Floor,       |   |                                               |      |   |                          |   |   |   |
| New      York, New York 10022             |   |                                               |      |   |                          |   |   |   |
| Barclays      Global Investors, NA        |   |                                               | 1,851,697 |   |                          |   | 7.52 |   |
| 45      Fremont Street                    |   |                                               |      |   |                          |   |   |   |
| San Francisco,      California 94105 |   |                                               |      |   |                          |   |   |   |
| Dimensional      Fund Advisors LP    |   |                                               | 1,685,698 |   |                          |   | 6.85 |   |
| 1299      Ocean Avenue                    |   |                                               |      |   |                          |   |   |   |
| Santa      Monica, California 90401       |   |                                               |      |   |                          |   |   |   |
| FMR      LLC                              |   |                                               | 1,450,300 |   |                          |   | 5.89 |   |
| 82      Devonshire Street                 |   |                                               |      |   |                          |   |   |   |
| Boston,      Massachusetts 02109          |   |                                               |      |   |                          |   |   |   |
| Royce &      Associates, LLC     |   |                                               | 1,360,583 |   |                          |   | 5.53 |   |
| 1414      Avenue of the Americas          |   |                                               |      |   |                          |   |   |   |
| New      York, New York 10019             |   |                                               |      |   |                          |   |   |   |

----

----

|   | • | each      Director; |
|--------|---------|---------------------|

|   | • | the      “named executive officers” of Gerber as set forth in the Fiscal 2009      Summary Compensation Tableabove; and |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | all      of Gerber's Directors and executive officers as a  group. |
|--------|---------|--------------------------------------------------------------------|

| Name      of Beneficial Owner                                             |   | Amount      and Nature ofBeneficial      Ownership |      |   | Percent      ofClass (%) |   |
|---------------------------------------------------------------------------|--------|----------------------------------------------------|-----------|--------|-------------------------------|--------|
| Donald      P. Aiken                                                      |   |                                               | 61,859    |   |                          |   | * |   |
| Michael      R. Elia                                                      |   |                                               | 54,841    |   |                          |   | * |   |
| Marc      T. Giles                                                        |   |                                               | 290,227   |   |                          |   | 1.17 |   |
| John      Hancock                                                         |   |                                               | 152,763   |   |                          |   | * |   |
| Edward      G. Jepsen                                                     |   |                                               | 316,283   |   |                          |   | 1.29 |   |
| Rodney      Larson                                                        |   |                                               | 34,830    |   |                          |   | * |   |
| Stephen      P. Lovass                                                    |   |                                               | 61,391    |   |                          |   | * |   |
| Randall      D. Ledford                                                   |   |                                               | 22,914    |   |                          |   | * |   |
| John      R. Lord                                                         |   |                                               | 37,914    |   |                          |   | * |   |
| Carole      F. St. Mark                                                   |   |                                               | 47,687    |   |                          |   | * |   |
| W.      Jerry Vereen                                                      |   |                                               | 51,428    |   |                          |   | * |   |
|                                                                      |   |                                               |      |   |                          |   |   |   |
| All      Directors and executive officers as a group    (17 persons) |   |                                               | 1,465,933 |   |                          |   | 5.83 |   |

| * | Less      than one percent. |
|---|-----------------------------|

----

|             Plan      Category |   |    Number      of securitiesto      be issued upon theexercise      of outstandingoptions,      warrants andrights      (#) (a) |      |   |     Weighted-averageexercise      price ofoutstanding      options,warrants      andrights($)      (b) |   |   | Number      of securitiesremaining      availablefor      future issuanceunder      equitycompensation      plans(excluding      securitiesin      column(a)) (#)(c) |   |
|--------------------------------------------------------------------------------------------|--------|------------------------------------------------------------------------------------------------------------------------------------------------|-----------|--------|----------------------------------------------------------------------------------------------------------------------------|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|                                                                                       |   |                                                                                                                                           |      |   |                                                                                                                       |   |   |                                                                                                                                                                 |   |
| Equity      compensation plans approved by shareholders                                    |   |                                                                                                                                           | 2,187,746 | (1)    |                                                                                                                       |   | 9.81   |                                                                                                                                                                 |   |   | 922,507 | (2) |

| (1) | Excludes      1,809 shares of restricted stock outstanding under the Gerber      Scientific, Inc. 2003 Employee Stock Option Plan and 976,350 shares      of restricted stock outstanding under the Gerber Scientific, Inc. 2006      Omnibus Incentive Plan as of April 30, 2009.                                                                                                             |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Represents      922,507 shares of common stock remaining available for issuance      pursuant to awards under the Gerber Scientific, Inc. 2006 Omnibus      Incentive Plan. Up to 922,507 of the shares of common stock remaining      available for issuance pursuant to awards under this plan may be issued      pursuant to awards other than upon the exercise of an option, warrant or      right. |

----

ITEM

ITEM

|                        |   | 2009   |      |   | 2008   |   |
|-----------------------------|--------|--------|-----------|--------|--------|--------|
|                        |   |   |      |   |   |   |
| Audit      services         |   | $      | 2,251,455 |   |   | $      | 3,161,120 |   |
| Audit-related      services |   |   | ---       |   |   |   | 219,154 |   |
| Tax      services           |   |   | 185,913   |   |   |   | 265,008 |   |
| All      other services     |   |   | 7,500     |   |   |   | 6,060 |   |
|    Total     |   | $      | 2,444,868 |   |   | $      | 3,651,342 |   |

----

----

ITEM

|                                                                  |                                                                                                                                                                                         | Page     |
|-----------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------|
| Management's Report on Internal Control over Financial      Reporting | 80                                                                                                                                                                                           |
| 1.                                                                    | Financial      Statements:                                                                                                                                                                   |     |
|                                                                  | Report of Independent Registered Public Accounting      Firm                                                                                                                                 | 81       |
|                                                                  | Consolidated Statements of Operations for the      fiscal years ended April 30, 2009, 2008 and 2007                                                                                          | 82       |
|                                                                  | Consolidated Balance Sheets as of April 30, 2009 and      2008                                                                                                                               | 83       |
|                                                                  | Consolidated Statements of Cash Flows for the fiscal      years ended April 30, 2009, 2008 and 2007                                                                                          | 84       |
|                                                                  | Consolidated Statements of Changes in      Shareholders' Equity for each of the three fiscal years in the period      ended April 30, 2009                                                   |  85 |
|                                                                  | Notes to Consolidated Financial    Statements                                                                                                                                                | 86-112   |
|                                                                  |                                                                                                                                                                                         |
| 2.                                                                    | Financial      Statement Schedules                                                                                                                                                           |
|                                                                  | All      financial statement schedules are omitted because they are not applicable      or the required information is shown in the consolidated financial      statements or notes thereto. |
|                                                                  |                                                                                                                                                                                         |     |
| 3.                                                                    | ExhibitsGerber      Scientific, Inc. herewith files or incorporates herein the following      exhibits:                                                                                 |

| ExhibitNumber |  Exhibit      Description                                                                                                                                                                                                                                                                         |
|---------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.1           | Support      Agreement among Gerber Scientific Canada Inc., Gerber Scientific, Inc.      ("Gerber") and Virtek Vision International, Inc., effective September 4,      2008 (incorporated herein by reference to Exhibit 2.1 to Gerber's Current      Report on Form 8-K filed on September 10, 2008). |
|          |                                                                                                                                                                                                                                                                                                   |
| 3.1           | Amended      and Restated Certificate of Incorporation of Gerber Scientific, Inc.      (incorporated herein by reference to Exhibit 3.1 to Gerber's Quarterly      Report on Form 10-Q for the fiscal quarter ended October 31,      2004).                                                            |
|          |                                                                                                                                                                                                                                                                                                   |
| 3.2           | Amended      and Restated By-laws of Gerber Scientific, Inc. (incorporated herein by      reference to Exhibit 3.2 to Gerber's Current Report on Form 8-K filed on      May 1, 2007).                                                                                                                  |
|          |                                                                                                                                                                                                                                                                                                   |
| 4.1           | Form      of common stock certificate of Gerber Scientific, Inc. (incorporated      herein by reference to Exhibit 4.1 to Gerber's Annual Report on Form 10-K      for the fiscal year ended April 30, 2007).                                                                                          |
|          |                                                                                                                                                                                                                                                                                                   |
| 10.1          | Gerber      Scientific, Inc. Non-Employee Director's Stock Grant Plan, as amended and      restated (incorporated herein by reference to Exhibit 10.1 to Gerber's      Quarterly Report on Form 10-Q for the fiscal quarter ended October 31,      2006).                                              |
|          |                                                                                                                                                                                                                                                                                                   |
| 10.2          | Gerber      Scientific, Inc. 1992 Non-Employee Director Stock Option Plan, as amended      and restated (incorporated herein by reference to Exhibit 10.2 to Gerber's      Annual Report on Form 10-K for the fiscal year ended April 30,      1999).                                                  |
|          |                                                                                                                                                                                                                                                                                                   |
| 10.3          | Gerber      Scientific, Inc. Agreement for Deferment of Director Fees, as amended      (incorporated herein by reference to Exhibit 10.1 to Gerber's Current      Report on Form 8-K filed on December 2, 2005).                                                                                       |
|          |                                                                                                                                                                                                                                                                                                   |
| 10.4          | Gerber      Scientific, Inc. 2006 Omnibus Incentive Plan, as amended (incorporated      herein by reference to Exhibit 10.1 to Gerber's Form 8-K filed on      September 25, 2008).                                                                                                                    |
|          |                                                                                                                                                                                                                                                                                                   |
| 10.5          | Letter      Agreement, dated as of December 7, 2001, between Gerber Scientific, Inc.      and Marc T. Giles (incorporated herein by reference to Exhibit 10.6 to      Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended      January 31, 2002).                                      |
|          |                                                                                                                                                                                                                                                                                                   |
| 10.6          | Letter      Agreement, dated as of March 14, 2008, between Gerber Scientific, Inc. and      Michael R. Elia (incorporated herein by reference to Exhibit 10.6 to      Gerber's Annual Report on Form 10-K for the fiscal year ended April 30,      2008).                                              |

----

| 10.7   | Form      of Restricted Stock Agreement under the Gerber Scientific, Inc. 2006      Omnibus Incentive Plan (incorporated herein by reference to Exhibit 99.1      to Gerber's Current Report on Form 8-K filed on November 9,      2006).                                                                                                   |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.8   | Form      of Nonqualified Stock Option Agreement under the Gerber Scientific, Inc.      2006 Omnibus Incentive Plan (incorporated herein by reference to Exhibit      99.2 to Gerber's Current Report on Form 8-K filed on November 9,      2006).                                                                                          |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.9   | Letter      Agreement, dated as of September 30, 2002, between Gerber Scientific, Inc.      and James S. Arthurs (incorporated herein by reference to Exhibit 10.15 of      Gerber's Annual Report on Form 10-K for the fiscal year ended April 30,      2003).                                                                             |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.10  | Letter      Agreement, dated as of December 7, 2001, between Gerber Scientific, Inc.      and John R. Hancock (incorporated herein by reference to Exhibit 10.8 to      Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended      January 31, 2002).                                                                         |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.11  | Form      of Change in Control Agreement, dated July 14, 1999, between Gerber      Scientific, Inc. and its Senior Vice Presidents, including Marc T. Giles      (incorporated herein by reference to Exhibit 10.2 to Gerber's Quarterly      Report on Form 10-Q for the fiscal quarter ended July 31,      1999).                         |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.12  | Severance      Policy for Senior Officers of Gerber Scientific, Inc. as Amended and      Restated Effective September 21, 2006 (incorporated herein by reference to      Exhibit 10.12 to Gerber's Annual Report on Form 10-K for the fiscal year      ended April 30, 2007).                                                               |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.13  | Agreement      and Lease between Spandex PLC and IM Properties Finance Limited for the      sale and leaseback of property in Bristol, United Kingdom (incorporated      herein by reference to Exhibit 10.3 to Gerber's Quarterly Report on Form      10-Q for the fiscal quarter ended January 31, 2001).                                 |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.14  | Lease      Agreement between GERB (CT) QRS 14-73, Inc. and Gerber Scientific, Inc.,      Gerber Technology, Inc., Gerber Scientific Products, Inc., and Gerber      Coburn Optical, Inc. (incorporated herein by reference to Exhibit 10.1 to      Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended July      31, 2001). |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.15  | Gerber      Scientific, Inc. and Participating Subsidiaries Supplemental Pension      Benefit Plan (incorporated herein by reference to Exhibit 10.5 to Gerber's      Annual Report on Form 10-K for the fiscal year ended April 30,      1999).                                                                                            |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.16  | First      Amendment to the Gerber Scientific, Inc. and Participating Subsidiaries      Supplemental Pension Benefit Plan.  Filed    herewith.                                                                                                                                                                                    |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.17  | Gerber      Scientific, Inc. 1992 Employee Stock Plan, as amended and restated      (incorporated herein by reference to Exhibit A to Gerber's Proxy Statement      on Schedule 14A filed on August 28, 1995).                                                                                                                              |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.18  | Gerber      Scientific, Inc. 2003 Employee Stock Option Plan, as amended and restated      (incorporated herein by reference to Exhibit 10.17 to Gerber's Annual      Report on Form 10-K for the fiscal year ended April 30,    2007).                                                                                                     |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.19  | Gerber      Scientific, Inc. 2005-2006 Executive Annual Incentive Bonus Plan      (incorporated herein by reference to Exhibit 4.3 to Gerber's Registration      Statement on Form S-8, File No. 333-116991).                                                                                                                               |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.20  | Letter      Agreement, dated as of October 1, 2004, between Gerber Scientific, Inc.      and William V. Grickis, Jr. (incorporated herein by reference to Exhibit      10.3 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter      ended October 31, 2004).                                                                  |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.21  | Letter      Agreement, dated as of December 18, 2003, between Gerber Scientific, Inc.      and Donald P. Aiken (incorporated herein by reference to Exhibit 10.33 to      Gerber's Annual Report on Form 10-K for the fiscal year ended April 30,      2004).                                                                               |
|   |                                                                                                                                                                                                                                                                                                                                        |
| 10.22  | Form      of Nonqualified Stock Option Agreement pursuant to the Gerber Scientific,      Inc. 2003 Employee Stock Option Plan (incorporated herein by reference to      Exhibit 10.1 to Gerber's Quarterly Report on Form 10-Q for the fiscal      quarter ended October 31,2004).                                                          |

----

| 10.23  | Form      of Restricted Stock Agreement pursuant to the Gerber Scientific, Inc. 2003      Employee Stock Option Plan (incorporated herein by reference to Exhibit      10.2 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter      ended October 31, 2004).                                                                                                                                                                                                                                                                                            |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 10.24  | Change      in Control Agreement, dated October 1, 2005, between Gerber Scientific,      Inc. and William V. Grickis, Jr. (incorporated herein by reference to      Exhibit 10.3 to Gerber's Quarterly Report on Form 10-Q for the fiscal      quarter ended October 31, 2004).                                                                                                                                                                                                                                                                                       |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 10.25  | Change      in Control Agreement, dated April 15, 2008, between Gerber Scientific,      Inc. and Michael R. Elia (incorporated herein by reference to Exhibit      10.24 to Gerber's Annual Report on Form 10-K for the fiscal year ended      April 30, 2008).                                                                                                                                                                                                                                                                                                       |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 10.26  | Credit      Agreement, dated as of January 31, 2008, among Gerber Scientific, Inc.,      certain subsidiaries of Gerber Scientific, Inc., JP Morgan Chase Bank      N.A., HSBC Bank USA, National Association, Merrill Lynch Capital      Corporation, Bank of America, N.A., Sovereign Bank as documentation agent,      Citizens Bank of Massachusetts as administrative agent, and RBS Greenwich      Capital as sole lead arranger (incorporated herein by reference to Exhibit      10.1 to Gerber's Current Report on Form 8-K filed on February 6,      2008). |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 10.27  | First      Amendment to Credit Agreement, dated as of November 21, 2008, among Gerber      Scientific, Inc., certain subsidiaries of Gerber Scientific, Inc., JP      Morgan Chase Bank N.A., HSBC Bank USA, National Association, Merrill Lynch      Capital Corporation, Bank of America, N.A., Sovereign Bank, and RBS      Citizens N.A. as lender and agent (incorporated herein by reference to      Exhibit 10.2 to Gerber's Quarterly Report on Form 10-Q for the fiscal      quarter ended October 31, 2008).                                                |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 10.28  | Second      Amendment to Credit Agreement, dated as of March 4, 2009, among Gerber      Scientific, Inc., certain subsidiaries of Gerber Scientific, Inc., JP      Morgan Chase Bank N.A., HSBC Bank USA, National Association, Merrill Lynch      Capital Corporation, Bank of America, N.A., Sovereign Bank, and RBS      Citizens N.A. as lender and agent.  Filed    herewith.                                                                                                                                                                          |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 10.29  | Letter      Agreement, dated as of November 3, 2007, between Gerber Scientific, Inc.      and Joseph R. Mele (incorporated herein by reference to Exhibit 10.26 to      Gerber's Annual Report on Form 10-K for the fiscal year ended April 30,      2008).                                                                                                                                                                                                                                                                                                           |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 10.30  | Change      in Control Agreement, dated March 4, 2008, between Gerber Scientific, Inc.      and Joseph R. Mele (incorporated herein by reference to Exhibit 10.27 to      Gerber's Annual Report on Form 10-K for the fiscal year ended April 30,      2008).                                                                                                                                                                                                                                                                                                         |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 21.1   | Subsidiaries      of Gerber.  Filed herewith.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 23.1   | Consent      of PricewaterhouseCoopers LLP, Independent Registered Public Accounting      Firm.  Filed herewith.                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 31.1   | Certification      of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)      under the Securities Exchange Act of 1934.  Filed      herewith.                                                                                                                                                                                                                                                                                                                                                                                            |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 31.2   | Certification      of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)      under the Securities Exchange Act of 1934.  Filed      herewith.                                                                                                                                                                                                                                                                                                                                                                                            |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 32     | Certification      of Chief Executive Officer and Chief Financial Officer pursuant Rule      13a-14(b) or Rule 15d-14(b) and to 18 U.S.C. §1350.  Filed      herewith.                                                                                                                                                                                                                                                                                                                                                                                 |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (b)    | See      Item 15(a) 3. above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| (c)    | See      Item 15(a) 2. above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

----

Management's

----

Report

----

Gerber 

|                                                | For      the Fiscal Years Ended April 30, |
|-----------------------------------------------------|-------------------------------------------|
| In      thousands of dollars, except per share data |                                      | 2009 |   |   | 2008 |   |   | 2007 |   |
| Revenue:                                            |                                      |   |   |   |   |   |   |   |   |
| Product      sales                                  |                                      | $ | 479,362 |   |   | $ | 565,945 |   |   | $ | 509,141 |   |
| Service      sales                                  |                                      |   | 73,452 |   |   |   | 74,072 |   |   |   | 65,657 |   |
|                                                |                                      |   | 552,814 |   |   |   | 640,017 |   |   |   | 574,798 |   |
| Cost      of Sales:                                 |                                      |   |   |   |   |   |   |   |   |   |   |   |
| Cost      of products sold                          |                                      |   | 350,722 |   |   |   | 403,776 |   |   |   | 362,215 |   |
| Cost      of services sold                          |                                      |   | 47,714 |   |   |   | 49,708 |   |   |   | 40,209 |   |
|                                                |                                      |   | 398,436 |   |   |   | 453,484 |   |   |   | 402,424 |   |
|                                                |                                      |   |   |   |   |   |   |   |   |   |   |   |
| Gross      profit                                   |                                      |   | 154,378 |   |   |   | 186,533 |   |   |   | 172,374 |   |
|                                                |                                      |   |   |   |   |   |   |   |   |   |   |   |
| Selling,      general and administrative expenses   |                                      |   | 125,726 |   |   |   | 135,297 |   |   |   | 124,460 |   |
| Research      and development                       |                                      |   | 22,417 |   |   |   | 26,187 |   |   |   | 24,282 |   |
| Operating      income                               |                                      |   | 6,235 |   |   |   | 25,049 |   |   |   | 23,632 |   |
|                                                |                                      |   |   |   |   |   |   |   |   |   |   |   |
| Other      income (expense), net                    |                                      |   | (4,190 | ) |   |   | (132 | ) |   |   | 524 |   |
| Interest      expense                               |                                      |   | (3,746 | ) |   |   | (4,165 | ) |   |   | (3,530 | ) |
| (Loss)      Income before income taxes              |                                      |   | (1,701 | ) |   |   | 20,752 |   |   |   | 20,626 |   |
| Income      tax (benefit) expense                   |                                      |   | (3,937 | ) |   |   | 6,248 |   |   |   | 7,118 |   |
| Net      income                                     |                                      | $ | 2,236 |   |   | $ | 14,504 |   |   | $ | 13,508 |   |
| Earnings      Per Share of Common Stock:            |                                      |   |   |   |   |   |   |   |   |   |   |   |
| Basic                                               |                                      | $ | 0.09  |   |   | $ | 0.62  |   |   | $ | 0.59  |   |
| Diluted                                             |                                      | $ | 0.09  |   |   | $ | 0.61  |   |   | $ | 0.58  |   |

----

Gerbe

|                                                                                                     |   | April      30, |    |
|----------------------------------------------------------------------------------------------------------|--------|----------------|---------|
| In      thousands of dollars and shares                                                                  |   | 2009           |    |   | 2008 |   |
| Assets:                                                                                                  |   |           |    |   |   |   |
| Current      Assets:                                                                                     |   |           |    |   |   |   |
| Cash      and cash equivalents                                                                           |   | $              | 10,313  |   |   | $ | 13,892 |   |
| Accounts      receivable (net of allowance for doubtful accounts of $6,741 and      $6,384)              |   |           | 87,798  |   |   |   | 120,752 |   |
| Inventories                                                                                              |   |           | 72,108  |   |   |   | 76,927 |   |
| Deferred      tax assets, net                                                                            |   |           | 9,022   |   |   |   | 7,600 |   |
| Prepaid      expenses and other current assets                                                           |   |           | 4,659   |   |   |   | 5,829 |   |
| Total      Current Assets                                                                                |   |           | 183,900 |   |   |   | 225,000 |   |
| Property,      plant and equipment, net                                                                  |   |           | 37,119  |   |   |   | 39,852 |   |
| Goodwill                                                                                                 |   |           | 76,940  |   |   |   | 61,844 |   |
| Deferred      tax assets, net                                                                            |   |           | 43,339  |   |   |   | 34,354 |   |
| Other      assets                                                                                        |   |           | 17,919  |   |   |   | 17,489 |   |
| Total      Assets                                                                                        |   | $              | 359,217 |   |   | $ | 378,539 |   |
| Liabilities      and Shareholders' Equity:                                                               |   |           |    |   |   |   |   |   |
| Current      Liabilities:                                                                                |   |           |    |   |   |   |   |   |
| Accounts      payable                                                                                    |   |  $        | 37,494  |   |   | $  | 51,253 |   |
| Accrued      compensation and benefits                                                                   |   |           | 15,735  |   |   |   | 23,671 |   |
| Other      accrued liabilities                                                                           |   |           | 24,748  |   |   |   | 27,672 |   |
| Deferred      revenue                                                                                    |   |           | 13,084  |   |   |   | 16,399 |   |
| Total      Current Liabilities                                                                           |   |           | 91,061  |   |   |   | 118,995 |   |
| Long-term      debt                                                                                      |   |           | 73,500  |   |   |   | 42,000 |   |
| Accrued      pension benefit liability                                                                   |   |           | 29,629  |   |   |   | 28,514 |   |
| Other      long-term liabilities                                                                         |   |           | 16,725  |   |   |   | 19,467 |   |
|                                                                                                     |   |           |    |   |   |   |   |   |
| Commitments      and contingencies (Note 18)                                                             |   |           |    |   |   |   |   |   |
|  Shareholders'      Equity:                                                                         |   |           |    |   |   |   |   |   |
| Preferred      stock, $0.01 par value; authorized 10,000 shares; no shares      issued                   |   |           | ---     |   |   |   | --- |   |
| Common      stock, $0.01 par value; authorized 100,000 shares; issued 25,174      and 24,300 shares |   |           | 252     |   |   |   | 243 |   |
| Paid-in      capital                                                                                     |   |           | 79,198  |   |   |   | 75,472 |   |
| Retained      earnings                                                                                   |   |           | 97,662  |   |   |   | 95,426 |   |
| Treasury      stock, 561 and 591 shares, at cost                                                         |   |           | (11,531 | ) |   |   | (12,148 | ) |
| Accumulated      other comprehensive (loss) income                                                       |   |           | (17,279 | ) |   |   | 10,570 |   |
| Total      Shareholders' Equity                                                                          |   |           | 148,302 |   |   |   | 169,563 |   |
| Total      Liabilities and Shareholders' Equity                                                          |   | $              | 359,217 |   |   | $ | 378,539 |   |

----

Gerber

|                                                                                    | For      the Fiscal Years Ended April 30, |   |
|-----------------------------------------------------------------------------------------|-------------------------------------------|--------|
| In      thousands of dollars                                                            |                                      | 2009   |   |   | 2008 |   |   | 2007 |   |
| Cash      flows from operating activities:                                              |                                      |   |   |   |   |   |   |   |   |
| Net      income                                                                         |                                      | $      | 2,236 |   |   | $ | 14,504 |   |   | $ | 13,508 |   |
| Adjustments      to reconcile net income to cash provided by operating      activities: |                                      |   |   |   |   |   |   |   |   |   |   |   |
| Depreciation      and amortization                                                      |                                      |   | 9,991 |   |   |   | 9,518 |   |   |   | 8,756 |   |
| Deferred      income taxes                                                              |                                      |   | (5,953 | ) |   |   | 2,501 |   |   |   | 1,609 |   |
| Other-than-temporary      impairment charge                                             |                                      |   | 2,290 |   |   |   | --- |   |   |   | --- |   |
| Stock-based      compensation                                                           |                                      |   | 3,241 |   |   |   | 1,805 |   |   |   | 1,751 |   |
| Gain      on sale of assets                                                             |                                      |   | (622 | ) |   |   | (2,287 | ) |   |   | --- |   |
| Other      noncash items                                                                |                                      |   | 2,220 |   |   |   | 2,191 |   |   |   | 1,293 |   |
| Changes      in operating accounts, excluding effects of acquisitions:                  |                                      |   |   |   |   |   |   |   |   |   |   |   |
| Accounts      receivable                                                                |                                      |   | 25,795 |   |   |   | (5,719 | ) |   |   | (11,618 | ) |
| Inventories                                                                             |                                      |   | 5,820 |   |   |   | (6,220 | ) |   |   | (9,624 | ) |
| Prepaid      expenses and other assets                                                  |                                      |   | 79 |   |   |   | 696 |   |   |   | (1,154 | ) |
| Accounts      payable and other accrued liabilities                                     |                                      |   | (27,424 | ) |   |   | (7,095 | ) |   |   | (3,221 | ) |
| Accrued      compensation and benefits                                                  |                                      |   | (7,899 | ) |   |   | 311 |   |   |   | (1,028 | ) |
| Net      cash provided by operating activities                                          |                                      |   | 9,774 |   |   |   | 10,205 |   |   |   | 272 |   |
| Cash      flows from investing activities:                                              |                                      |   |   |   |   |   |   |   |   |   |   |   |
| Capital      expenditures                                                               |                                      |   | (8,187 | ) |   |   | (8,589 | ) |   |   | (3,945 | ) |
| Proceeds      from sale of available for sale investments                               |                                      |   | 705 |   |   |   | 751 |   |   |   | 6,216 |   |
| Purchases      of available for sale investments                                        |                                      |   | (457 | ) |   |   | (753 | ) |   |   | (6,037 | ) |
| Proceeds      from sale of assets                                                       |                                      |   | 2,622 |   |   |   | 345 |   |   |   | --- |   |
| Business      acquisitions                                                              |                                      |   | (34,273 | ) |   |   | (4,650 | ) |   |   | (1,510 | ) |
| Intangible      assets expenditures                                                     |                                      |   | (828 | ) |   |   | (868 | ) |   |   | (625 | ) |
| Net      cash used for investing activities                                             |                                      |   | (40,418 | ) |   |   | (13,764 | ) |   |   | (5,901 | ) |
| Cash      flows from financing activities:                                              |                                      |   |   |   |   |   |   |   |   |   |   |   |
| Debt      repayments                                                                    |                                      |   | (80,271 | ) |   |   | (314,256 | ) |   |   | (301,560 | ) |
| Debt      proceeds                                                                      |                                      |   | 110,686 |   |   |   | 321,862 |   |   |   | 297,756 |   |
| Debt      issuance costs                                                                |                                      |   | (1,174 | ) |   |   | (993 | ) |   |   | --- |   |
| Common      stock issued                                                                |                                      |   | 898 |   |   |   | 1,373 |   |   |   | 3,921 |   |
| Net      cash provided by financing activities                                          |                                      |   | 30,139 |   |   |   | 7,986 |   |   |   | 117 |   |
| Effect      of exchange rate changes on cash                                            |                                      |   | (3,074 | ) |   |   | 1,413 |   |   |   | (581 | ) |
| (Decrease) Increase      in cash and cash equivalents                              |                                      |   | (3,579 | ) |   |   | 5,840 |   |   |   | (6,093 | ) |
| Cash      and cash equivalents at beginning of year                                     |                                      |   | 13,892 |   |   |   | 8,052 |   |   |   | 14,145 |   |
| Cash      and cash equivalents at end of year                                           |                                      | $      | 10,313 |   |   | $ | 13,892 |   |   | $ | 8,052 |   |
|                                                                                    |                                      |   |   |   |   |   |   |   |   |   |   |   |
| Supplemental      Schedule of Cash Flow Information                                     |                                      |   |   |   |   |   |   |   |   |   |   |   |
| Cash      paid during the year for:                                                     |                                      |   |   |   |   |   |   |   |   |   |   |   |
| Interest                                                                                |                                      | $      | 2,856 |   |   | $ | 3,655 |   |   | $ | 3,232 |   |
| Income      taxes, net of refunds                                                       |                                      | $      | 4,456 |   |   | $ | 5,290 |   |   | $ | 3,333 |   |

----

Gerber 

| In      thousands of dollars and shares                                                                                                  | IssuedCommonStockShares |   | CommonStock | Paid-inCapital |   | RetainedEarnings |   | TreasuryStock |   | Unamort.Value      ofRestrict.StockGrants |   | Accum.OtherComp.Income(Loss) |   | Total  |   |
|------------------------------------------------------------------------------------------------------------------------------------------|-------------------------|--------|-------------|----------------|--------|------------------|--------|---------------|--------|-------------------------------------------|--------|------------------------------|--------|--------|--------|
| Balance      as of April 30, 2006                                                                                                        | 23,265                  |   |        | $              | 233    |             |   | $             | 67,339 |                                      |   | $                            | 69,782 |   | $      | (13,496 | ) |   | $ | (136 | ) |   | $ | 1,894 |   |   | $ | 125,616 |   |
| Net      income                                                                                                                          | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | 13,508 |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | 13,508 |   |
| Currency      translation adjustments                                                                                                    | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | 7,266 |   |   |   | 7,266 |   |
| Unrealized      loss on securities, net of reclassification adjustment of      $(989)    and      tax of $(273)      | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | (462 | ) |   |   | (462 | ) |
| Minimum      pension liability change, net    of      tax of $(863)                                                  | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | 1,384 |   |   |   | 1,384 |   |
| Comprehensive      income                                                                                                                |                    |   |        |           |   |             |   |          |   |                                      |   |                         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | 21,696 |   |
| Initial      application of SFAS 158, net of     tax      of $5,300                                             | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | (8,927 | ) |   |   | (8,927 | ) |
| Cumulative      effect of adoption of SFAS 123(R)                                                                                        | --                      |   |        |           | --     |             |   |          | (136   | )                                         |   |                         | --     |   |   | -- |   |   |   | 136 |   |   |   | -- |   |   |   | -- |   |
| Stock      issued to Directors                                                                                                           | --                      |   |        |           | --     |             |   |          | (258   | )                                         |   |                         | --     |   |   | 682 |   |   |   | -- |   |   |   | -- |   |   |   | 424 |   |
| Stock      issued under employee plans, net                                                                                              | 513                     |   |        |           | 5      |             |   |          | 3,978  |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | 3,983 |   |
| Stock      based compensation expense                                                                                                    | --                      |   |        |           | --     |             |   |          | 1,581  |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | 1,581 |   |
| Restricted      stock grants and cancellations, net of amortization                                                                      | 31                      |   |        |           | --     |             |   |          | 108    |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | 108 |   |
| Balance      as of April 30, 2007                                                                                                        | 23,809                  |   |        | $              | 238    |             |   | $             | 72,612 |                                      |   | $                            | 83,290 |   | $      | (12,814 | ) |   | $ | -- |   |   | $ | 1,155 |   |   | $ | 144,481 |   |
| Net      income                                                                                                                          | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | 14,504 |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | 14,504 |   |
| Currency      translation adjustments                                                                                                    | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | 11,686 |   |   |   | 11,686 |   |
| Unrealized      loss on securities, net of reclassification adjustment of $26      and    tax      of $(289)         | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | (486 | ) |   |   | (486 | ) |
| Change      in pension plans, net of tax of $1,059                                                                                       | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | (1,785 | ) |   |   | (1,785 | ) |
| Comprehensive      income                                                                                                                |                    |   |        |           |   |             |   |          |   |                                      |   |                         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | 23,919 |   |
| Cumulative      effect of adoption of FIN 48                                                                                             | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | (2,368 | )      |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | (2,368 | ) |
| Stock      issued to Directors                                                                                                           | --                      |   |        |           | --     |             |   |          | (323   | )                                         |   |                         | --     |   |   | 666 |   |   |   | -- |   |   |   | -- |   |   |   | 343 |   |
| Stock      issued under employee plans, net                                                                                              | 216                     |   |        |           | 2      |             |   |          | 1,381  |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | 1,383 |   |
| Stock      based compensation expense                                                                                                    | --                      |   |        |           | --     |             |   |          | 1,408  |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | 1,408 |   |
| Restricted      stock grants and cancellations, net of amortization                                                                      | 275                     |   |        |           | 3      |             |   |          | 394    |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | 397 |   |
| Balance      as of April 30, 2008                                                                                                        | 24,300                  |   |        | $              | 243    |             |   | $             | 75,472 |                                      |   | $                            | 95,426 |   | $      | (12,148 | ) |   | $ | -- |   |   | $ | 10,570 |   |   | $ | 169,563 |   |
| Net      income                                                                                                                          | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | 2,236  |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | 2,236 |   |
| Currency      translation adjustments                                                                                                    | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | (25,709 | ) |   |   | (25,709 | ) |
| Unrealized      gain on securities, net of reclassification adjustment of $2,423      and      tax of $341 | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | 574 |   |   |   | 574 |   |
| Change      in pension plans, net of tax of $1,172                                                                                       | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | (1,973 | ) |   |   | (1,973 | ) |
| Change      in derivative instruments, net of    tax      of $440                                                    | --                      |   |        |           | --     |             |   |          | --     |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | (741 | ) |   |   | (741 | ) |
| Comprehensive      loss                                                                                                                  |                    |   |        |           |   |             |   |          |   |                                      |   |                         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (25,613 | ) |
| Stock      issued to Directors                                                                                                           | --                      |   |        |           | --     |             |   |          | (407   | )                                         |   |                         | --     |   |   | 617 |   |   |   | -- |   |   |   | -- |   |   |   | 210 |   |
| Stock      issued under employee plans, net                                                                                              | 131                     |   |        |           | 1      |             |   |          | 900    |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | 901 |   |
| Stock      based compensation expense                                                                                                    | --                      |   |        |           | --     |             |   |          | 2,032  |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | 2,032 |   |
| Restricted      stock grants and cancellations, net of amortization                                                                      | 743                     |   |        |           | 8      |             |   |          | 1,201  |                                      |   |                         | --     |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | 1,209 |   |
| Balance      as of April 30, 2009                                                                                                        | 25,174                  |   |        | $              | 252    |             |   | $             | 79,198 |                                      |   | $                            | 97,662 |   | $      | (11,531 | ) |   | $ | -- |   |   | $ | (17,279 | ) |   | $ | 148,302 |   |

----

Gerber

----

----

| ·   | persuasive      evidence of an arrangement exists; |
|--------------------|----------------------------------------------------|

| ·   | delivery      has occurred or services have beenrendered; |
|--------------------|-----------------------------------------------------------|

| ·   | the      price is fixed or determinable; and |
|--------------------|----------------------------------------------|

| ·   | collectibility      is reasonably assured |
|--------------------|-------------------------------------------|

| ·   | The equipment the Company      sells has value on a stand-alone basis. The Company's customers may      resell equipment on a stand-alone basis and there is an observable market      for the equipment.  The Company also may sell the equipment      without installation, training or service agreements. In these cases, the      overall sales price is reduced by an amount equal to the fair value of any      undelivered elements, asapplicable. |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | There is objective and      reliable evidence of the fair value of the undelivered items, as      applicable. The Company calculates the fair value of these elements      based on the same, or similar, services provided to customers on a      stand-alone basis. |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | There are no general rights of      return relating to the equipment.  The Company has no      obligation to accept the return of products sold other than for repair or      replacement of defective products, which must be authorized in      advance. |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

----

----

| In      thousands | Balance      atBeginning      ofFiscal      Year |   | Charges      toCosts      andExpenses1 |   | Deductions2 |   | Balance      atEnd      ofFiscal      Year |   |
|-------------------|--------------------------------------------------|--------|----------------------------------------|--------|-------------|--------|--------------------------------------------|--------|
| Fiscal      2009  |                                             | $      | 6,384                                  |   |        | $      | 2,733                                      |   |   | $ | (2,376 | )   |   | $ | 6,741 |   |
| Fiscal      2008  |                                             | $      | 7,012                                  |   |        | $      | 2,524                                      |   |   | $ | (3,152 | )   |   | $ | 6,384 |   |
| Fiscal      2007  |                                             | $      | 7,016                                  |   |        | $      | 2,829                                      |   |   | $ | (2,833 | )   |   | $ | 7,012 |   |

|   | 2      Deductions include accounts receivable written off and      recoveries. |
|--------|--------------------------------------------------------------------------------|

|                                   |   | April      30, |   |
|----------------------------------------|--------|----------------|--------|
| In      thousands                      |   | 2009           |   |   | 2008 |   |
| Raw      materials and purchased parts |   | $              | 58,779 |   |   | $ | 64,230 |   |
| Work      in process                   |   |           | 1,847  |   |   |   | 2,894 |   |
| Finished      goods                    |   |           | 11,482 |   |   |   | 9,803 |   |
| Total      inventories                 |   | $              | 72,108 |   |   | $ | 76,927 |   |

|                                          |   | April      30, |     |
|-----------------------------------------------|--------|----------------|----------|
| In      thousands                             |   | 2009           |     |   | 2008 |   |
| Land                                          |   | $              | 1,020    |   |   | $ | 1,218 |   |
| Buildings                                     |   |           | 35,166   |   |   |   | 38,405 |   |
| Machinery,      tools and equipment           |   |           | 96,457   |   |   |   | 109,530 |   |
|                                          |   |           | 132,643  |   |   |   | 149,153 |   |
| Accumulated      depreciation                 |   |           | (101,091 | ) |   |   | (113,081 | ) |
|                                          |   |           | 31,552   |   |   |   | 36,072 |   |
| Construction      in progress                 |   |           | 5,567    |   |   |   | 3,780 |   |
| Total      property, plant and equipment, net |   | $              | 37,119   |   |   | $ | 39,852 |   |

----

|  In    thousands                                        |   | October      21, 2008 |   |
|--------------------------------------------------------------|--------|-----------------------|--------|
| Assets      acquired:                                        |   |                  |   |
| Cash      and cash equivalents                               |   | $                     | 4,128  |   |
| Accounts      receivable                                     |   |                  | 6,940  |   |
| Inventories                                                  |   |                  | 8,756  |   |
| Prepaid      and other assets                                |   |                  | 615    |   |
| Property,      plant and equipment                           |   |                  | 1,831  |   |
| Goodwill                                                     |   |                  | 16,009 |   |
| Deferred      tax assets                                     |   |                  | 3,030  |   |
| Other      assets                                            |   |                  | 3,135  |   |
|      Total      assets acquired     |   | $                     | 44,444 |   |
| Liabilities      assumed:                                    |   |                  |   |   |
| Accounts      payable                                        |   | $                     | 2,499  |   |
| Accrued      compensation and benefits                       |   |                  | 2,954  |   |
| Other      liabilities                                       |   |                  | 5,579  |   |
| Deferred      revenue                                        |   |                  | 959    |   |
|      Total      liabilities assumed |   | $                     | 11,991 |   |
| Net      assets acquired                                     |   | $                     | 32,453 |   |

----

| In      thousands                                      | May      1, 2007 |   |
|--------------------------------------------------------|------------------|--------|
| Assets      acquired:                                  |             |   |   |
| Cash      and cash equivalents                         |             | $      | 500 |   |
| Accounts      receivable                               |             |   | 701 |   |
| Inventories                                            |             |   | 2,106 |   |
| Prepaid      expenses and other current assets         |             |   | 71 |   |
| Property,      plant and equipment                     |             |   | 450 |   |
| Goodwill                                               |             |   | 5,954 |   |
| Other      assets                                      |             |   | 68 |   |
|     Total      assets acquired     |             | $      | 9,850 |   |
| Liabilities      assumed:                              |             |   |   |   |
| Accounts      payable                                  |             | $      | 1,447 |   |
| Accrued      compensation and benefits                 |             |   | 139 |   |
| Other      accrued liabilities                         |             |   | 841 |   |
| Deferred      revenue                                  |             |   | 1,038 |   |
| Deferred      income taxes                             |             |   | 223 |   |
| Long-term      debt                                    |             |   | 1,012 |   |
|     Total      liabilities assumed |             | $      | 4,700 |   |
| Net      assets acquired                               |             | $      | 5,150 |   |

|                                   |   | April      30, 2009 |   |                    | April      30, 2008 |   |
|----------------------------------------|--------|---------------------|--------|-------------------------|---------------------|--------|
| In      thousands                      |   | GrossCarryingAmount |   | AccumulatedAmortization |                |   | Gross Carrying Amount |   | AccumulatedAmortization |   |
| Amortized      intangible assets:      |   |                |   |                    |                |   |   |   |   |   |   |   |
| Patents                                |   | $                   | 7,603  |                    |                | $      | 3,210 |   |   | $ | 7,512 |   |   | $ | 3,062 |   |
| Other                                  |   |                | 5,131  |                    |                |   | 739 |   |   |   | 646 |   |   |   | 413 |   |
| Total      amortized intangible assets |   | $                   | 12,734 |                    |                | $      | 3,949 |   |   | $ | 8,158 |   |   | $ | 3,475 |   |

----

| In      thousands                               | Sign      Making&      SpecialtyGraphics |   | Apparel      &FlexibleMaterials |   | OphthalmicLensProcessing |   |   | Total  |   |
|-------------------------------------------------|----------------------------------------------|--------|-------------------------------------|--------|--------------------------|--------|--------|--------|--------|
| Balance      as of April 30, 2007               |                                         | $      | 23,923                              |   |                     | $      | 13,906 |   |   | $ | 16,996 |   |   | $ | 54,825 |   |
| Business      acquisition                       |                                         |   | 5,862                               |   |                     |   | 25     |   |   |   | --- |   |   |   | 5,887 |   |
| Effects      of currency translation            |                                         |   | 914                                 |   |                     |   | 218    |   |   |   | --- |   |   |   | 1,132 |   |
| Balance      as of April 30, 2008               |                                         | $      | 30,699                              |   |                     | $      | 14,149 |   |   | $ | 16,996 |   |   | $ | 61,844 |   |
| Business      acquisitions                      |                                         |   | ---                                 |   |                     |   | 20,245 |   |   |   | --- |   |   |   | 20,245 |   |
| Adjustment      to previously reported goodwill |                                         |   | 92                                  |   |                     |   | ---    |   |   |   | --- |   |   |   | 92 |   |
| Effects      of currency translation            |                                         |   | (5,054                              | )      |                     |   | (187   | )      |   |   | --- |   |   |   | (5,241 | ) |
| Balance      as of April 30, 2009               |                                         | $      | 25,737                              |   |                     | $      | 34,207 |   |   | $ | 16,996 |   |   | $ | 76,940 |   |

|              |   | For      the Fiscal Years Ended April 30, |   |
|-------------------|--------|-------------------------------------------|--------|
|              |   | 2009                                      |   |   | 2008 |   |
| In      thousands |   | Cost                                      |   | Unrealized Gains |   | Estimated Fair      Value |   |   | Cost |   |   | UnrealizedLosses |   |   | Estimated Fair      Value |   |
| Mutual      funds |   | $                                         | 2,796  |   |   | $ | 159 |   |   | $ | 2,955  |   |   | $ | 5,461  |   |   | $ | (756 | ) |   | $ | 4,705  |   |

----

|                    |   | For      the Fiscal Years Ended April 30, |     |
|-------------------------|--------|-------------------------------------------|----------|
| In      thousands       |   | 2009                                      |     |   | 2008 |   |   | 2007 |   |
| Current:                |   |                                      |     |   |   |   |   |   |   |
| Federal                 |   | $                                         | (270     | ) |   | $ | (1,602 | ) |   | $ | (232 | ) |
| State      and local    |   |                                      |  95 |   |   |   | 273 |   |   |   | 223 |   |
| Foreign                 |   |                                      | 1,979    |   |   |   | 6,406 |   |   |   | 4,805 |   |
| Total      current      |   |                                      | 1,804    |   |   |   | 5,077 |   |   |   | 4,796 |   |
| Deferred:               |   |                                      |     |   |   |   |   |   |   |   |   |   |
| Federal                 |   |                                      | (3,134   | ) |   |   | 900 |   |   |   | 1,521 |   |
| State      and local    |   |                                      | (106     | ) |   |   | 128 |   |   |   | 278 |   |
| Foreign                 |   |                                      | (2,501   | ) |   |   | 143 |   |   |   | 523 |   |
| Total      deferred     |   |                                      | (5,741   | ) |   |   | 1,171 |   |   |   | 2,322 |   |
| Income      tax expense |   | $                                         | (3,937   | ) |   | $ | 6,248 |   |   | $ | 7,118 |   |

|                                                                   | For      the Fiscal Years Ended April 30, |   |
|------------------------------------------------------------------------|-------------------------------------------|--------|
|                                                                   |                                      | 2009   |   |   | 2008 |   |   | 2007 |   |
| Statutory      U.S. federal income tax rate                            |                                      |   | 35.0 |  % |   |   | 35.0 | %  |   |   | 35.0 | % |
| State      income taxes, net of US federal tax benefit                 |                                      |   | (3.7 | )  |   |   | 1.3 |   |   |   | 1.5 |   |
| Reversal      of valuation allowance in France                         |                                      |   | 190.7 |   |   |   | --- |   |   |   | --- |   |
| Foreign      tax differences and other valuation allowance adjustments |                                      |   | (47.2 | )  |   |   | 1.0 |   |   |   | 1.9 |   |
| Export      tax incentives                                             |                                      |   | --- |   |   |   | --- |   |   |   | (1.3 | ) |
| Research      and development tax credits                              |                                      |   | 20.9 |     |   |   | (2.0 | )    |   |   | (2.8 | ) |
| Adjustment      of prior years' tax estimates                          |                                      |   | 34.0 |     |   |   | (7.0 | )    |   |   | (0.6 | ) |
| Other,      net                                                        |                                      |   | 1.8 |   |   |   | 1.8 |   |   |   | 0.8 |   |
| Effective      income tax rate                                         |                                      |   | 231.5 |  % |   |   | 30.1 | %  |   |   | 34.5 | % |

----

|                                   | April      30, 2009     |    | April      30, 2008          |   |
|----------------------------------------|-------------------------|---------|------------------------------|--------|
| In      thousands                      | DeferredTax      Assets |    | Deferred      TaxLiabilities |   | DeferredTax      Assets |   | Deferred      TaxLiabilities |   |
| Depreciation                           | $                       | 1,452   |                         |   | $ | 1,265 |   | $ | 1,332 |   |   | $ | 1,704 |   |
| Patents                                |                    | ---     |                         |   |   | 1,519 |   |   | --- |   |   |   | 1,517 |   |
| Employee      benefit plans            |                    | 12,097  |                         |   |   | 154 |   |   | 11,935 |   |   |   | 95 |   |
| Inventory                              |                    | 5,639   |                         |   |   | --- |   |   | 3,641 |   |   |   | --- |   |
| Asset      valuations                  |                    | 13,734  |                         |   |   | 6,799 |   |   | 13,570 |   |   |   | 5,815 |   |
| Provisions      for estimated expenses |                    | 3,442   |                         |   |   | --- |   |   | 3,262 |   |   |   | 73 |   |
| Net      operating losses              |                    | 23,902  |                         |   |   | --- |   |   | 16,584 |   |   |   | --- |   |
| Credit      carryforwards              |                    | 7,133   |                         |   |   | 270 |   |   | 5,137 |   |   |   | --- |   |
| Other                                  |                    | 1,843   |                         |   |   | 805 |   |   | 1,789 |   |   |   | 550 |   |
|                                   |                    | 69,242  |                         |   |   | 10,812 |   |   | 57,250 |   |   |   | 9,754 |   |
| Valuation      allowance               |                    | (17,752 | )                            |   |   | --- |   |   | (16,144 | ) |   |   | --- |   |
|                                   | $                       | 51,490  |                         |   | $ | 10,812 |   | $ | 41,106 |   |   | $ | 9,754 |   |

|                            | For      the Fiscal Years Ended April 30, |    |
|---------------------------------|-------------------------------------------|---------|
| In      thousands               | 2009                                      |    |   | 2008 |   |   | 2007 |   |
| United      States              | $                                         | (11,963 | ) |   | $ | 439 |   |   | $ | 4,489 |   |
| Foreign                         |                                      | 10,262  |   |   |   | 20,313 |   |   |   | 16,137 |   |
| Income      before income taxes | $                                         | (1,701  | ) |   | $ | 20,752 |   |   | $ | 20,626 |   |

----

| In      thousands | Balance      atBeginning      ofFiscal      Year | Charges      to Income Tax      Expense |   | Acquired      ValuationAllowances |   | Deductions | 1     | Balance      atEnd      ofFiscal      Year |   |
|-------------------|--------------------------------------------------|---------------------------------------------------|--------|-----------------------------------|--------|------------|-------|--------------------------------------------|--------|
| Fiscal      2009  |                                             | $                                                 | 16,144 |                              |   | $          | 1,511 |                                       |   | $ | 3,415 |   |   | $ | (3,318 | ) |   | $ | 17,752 |   |
| Fiscal      2008  |                                             | $                                                 | 15,043 |                              |   | $          | 1,188 |                                       |   | $ | --- |   |   | $ | (87 | ) |   | $ | 16,144 |   |
| Fiscal      2007  |                                             | $                                                 | 14,292 |                              |   | $          | 1,227 |                                       |   | $ | --- |   |   | $ | (476 | ) |   | $ | 15,043 |   |

| In      thousands                                              |   |   |  2009 |   |   | 2008   |   |
|----------------------------------------------------------------|--------|--------|------------|--------|--------|--------|--------|
| Beginning      balance                                         |   | $      | 4,064      |   |   | $      | 5,061  |   |
| Additions      for tax positions related to the current year   |   |   | 140        |   |   |   | 74     |   |
| Additions      for tax positions of prior years                |   |   | 37         |   |   |   | 292    |   |
| Reductions      for tax positions of prior years               |   |   | (196       | )      |   |   | (374   | ) |
| Reductions      for lapse of applicable statutes of limitation |   |   | (623       | )      |   |   | (989   | ) |
| Settlements                                                    |   |   | ---        |   |   |   | ---    |   |
| Ending      balance                                            |   | $      | 3,422      |   |   | $      | 4,064  |   |

|                                  | April      30, 2009  |   |   | April      30, |   |
|---------------------------------------|----------------------|--------|--------|----------------|--------|
| In      thousands                     | Effective      rates |   |   | 2009           |   |   | 2008 |   |
| Short-term      lines of credit       |                 |   | 4.67   | %              |   | $ | 189 |   |   | $ | --- |   |
| Revolving      credit facility        |                 |   | 5.33   | %              |   |   | 67,500 |   |   |   | 36,000 |   |
| Industrial      development bonds     |                 |   | 3.15   | %              |   |   | 6,000 |   |   |   | 6,000 |   |
|                                  |                 |   |   |           |   |   | 73,689 |   |   |   | 42,000 |   |
| Less      portion due within one year |                 |   |   |           |   |   | (189 | ) |   |   | --- |   |
| Total      long-term debt             |                 |   |   |           |   | $ | 73,500 |   |   | $ | 42,000 |   |

----

| Total      Funded Debt to Consolidated EBITDA Ratio |   | ABR      Margin(basis      points) |   |   | LIBOR      Margin(basis      points) |   |   | Commitment      Fee (basis points) |   |
|-----------------------------------------------------|--------|------------------------------------|--------|--------|--------------------------------------|--------|--------|------------------------------------|--------|
| 3.00x      and greater                              |   |                               | 300.0  |   |                                 |   | 400.0  |                               |   |   | 50.0 |   |
| 2.25x      to less than 3.00x                       |   |                               | 225.0  |   |                                 |   | 325.0  |                               |   |   | 50.0 |   |
| 1.50x      to less than 2.25x                       |   |                               | 175.0  |   |                                 |   | 275.0  |                               |   |   | 37.5 |   |
| 0.75x      to less than 1.50x                       |   |                               | 137.5  |   |                                 |   | 237.5  |                               |   |   | 25.0 |   |
| Less      than 0.75x                                |   |                               | 100.0  |   |                                 |   | 200.0  |                               |   |   | 25.0 |   |

----

----

| In      thousands                                            | Balance      Sheet Location          |   | Liabilities |   |
|--------------------------------------------------------------|--------------------------------------|--------|-------------|--------|
| Derivatives      designated as hedging instruments:          |                                 |   |        |   |
|     Interest      rate swap arrangements | Other      accrued liabilities  |   | $           | 1,181  |   |

| In      thousands                                                                                                                                                    |   | 2009 |   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|------|--------|
| Loss      recognized in Accumulated Other Comprehensive Income (Loss) in      Shareholders' Equity before tax effect                                                 |   | $    | 1,181  |   |
| Loss      reclassified from Accumulated Other Comprehensive Income (Loss) in      Shareholders' Equity to Interest   Expense      (effective portion) |   | $    | 301    |   |

----

|                          | For      the Fiscal Years Ended April 30,                                                                                                                                                                                                                                                                                                                                                                                                        |           |
|-------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------|
|                          | 2009                                                                                                                                                                                                                                                                                                                                                                                                                                             | 2008           | 2007 |   |
| Expected      option term1    | 5.5      years                                                                                                                                                                                                                                                                                                                                                                                                                                   | 5.9      years | 5.6      years |   |
| Expected      volatility2     | 46.3%                                                                                                                                                                                                                                                                                                                                                                                                                                            | 51%            | 55% |   |
| Risk-free      interest rate3 | 3.0%                                                                                                                                                                                                                                                                                                                                                                                                                                             | 3.2%           | 4.4% |   |
| 1                             | The      option term was determined using the simplified method for estimating      expected option life through December 31, 2007.  The Company's      options qualify as "plain-vanilla" options, as defined in the SEC's Staff      Accounting Bulletin No. 107, "Share-Based Payment."  Beginning      on January 1, 2008, the expected option term is determined by analyzing      the Company's historical experience. |           |
| 2                             | The      stock volatility for each grant is measured using the weighted-average of      historical daily price changes of the Company's common stock over the most      recent period equal to the expected option life of the    grant.                                                                                                                                                                                                         |           |
| 3                             | The      risk-free interest rate is based on the 5-year U.S. Treasury note      yield in effect at the time of grant.                                                                                                                                                                                                                                                                                                                       |           |

----

|                                          | Shares(in Thousands) |   | Weighted-averageExercisePrice |   | Weighted-averageRemainingContractualTerm | AggregateIntrinsicValue(in      millions) |   |
|-----------------------------------------------|---------------------------|--------|-------------------------------|--------|------------------------------------------|-------------------------------------------|--------|
| Outstanding      as of April 30, 2008         |                      |   | 2,117                         |   |                                     | $                                         | 10.42  |   | 5.8      years |   | $ | 2.0 |   |
| Options      granted                          |                      |   | 402                           |   |                                     | $                                         | 8.49   |   |   |   |   |   |   |
| Options      exercised                        |                      |   | (139                          | )      |                                     | $                                         | 6.84   |   |   |   | $ | 0.6 |   |
| Options      canceled                         |                      |   | (192                          | )      |                                     | $                                         | 15.74  |   |   |   |   |   |   |
| Outstanding      as of April 30, 2009         |                      |   | 2,188                         |   |                                     | $                                         | 9.81   |   | 5.6      years |   | $ | 0.1 |   |
| Options      exercisable as of April 30, 2009 |                      |   | 1,391                         |   |                                     | $                                         | 9.77   |   | 4.0      years |   | $ | 0.1 |   |

|                                                        | For      the Fiscal Years Ended April 30, |   |
|-------------------------------------------------------------|-------------------------------------------|--------|
|                                                        |                                      | 2009   |   |   | 2008 |   |   | 2007 |   |
| Restricted      stock awarded (shares in thousands)         |                                      |   | 767 |   |   |   | 288 |   |   |   | 32 |   |
| Weighted-average      fair value on date of grant per share |                                      | $      | 4.52 |   |   | $ | 9.65 |   |   | $ | 14.06 |   |

| In      thousands except per share amounts |   | Shares |   | Weighted-averageFair      Value |   |
|--------------------------------------------|--------|--------|--------|---------------------------------|--------|
| Nonvested      as of April 30, 2008        |   |   | 308    |                            |   | $ | 9.91 |   |
| Granted                                    |   |   | 767    |                            |   |   | 4.52 |   |
| Vested                                     |   |   | (73    | )                               |   |   | 10.01 |   |
| Forfeited                                  |   |   | (24    | )                               |   |   | 9.05 |   |
| Nonvested      as of April 30, 2009        |   |   | 978    |                            |   | $ | 5.70 |   |

----

| In      thousands                    |   | Foreign      Currency Translation Adjustment |    | Unrealized      Gain (Loss) on Available for Sale Securities |   | Net      Loss on Derivative Instruments |   | Minimum      Pension Liability Adjustment |   | Accumulated      Other Comprehensive  (Loss) Income |   |
|--------------------------------------|--------|----------------------------------------------|---------|--------------------------------------------------------------|--------|-----------------------------------------|--------|-------------------------------------------|--------|---------------------------------------------------------------|--------|
| Balance      as of April 30, 2006    |   | $                                            | 7,169   |                                                         |   | $                                       | 474    |                                      | $      | ---                                                           |   | $ | (5,749 | ) | $ | 1,894 |   |
| Fiscal      2007 activity            |   |                                         | 7,266   |                                                         |   |                                    | (462   | )                                         |   | ---                                                           |   |   | 1,384 |   |   | 8,188 |   |
| Initial      application of SFAS 158 |   |                                         | ---     |                                                         |   |                                    | ---    |                                      |   | ---                                                           |   |   | (8,927 | ) |   | (8,927 | ) |
| Balance      as of April 30, 2007    |   |                                         | 14,435  |                                                         |   |                                    | 12     |                                      |   | ---                                                           |   |   | (13,292 | ) |   | 1,155 |   |
| Fiscal      2008 activity            |   |                                         | 11,686  |                                                         |   |                                    | (486   | )                                         |   | ---                                                           |   |   | (1,785 | ) |   | 9,415 |   |
| Balance      as of April 30, 2008    |   |                                         | 26,121  |                                                         |   |                                    | (474   | )                                         |   | ---                                                           |   |   | (15,077 | ) |   | 10,570 |   |
| Fiscal      2009 activity            |   |                                         | (25,709 | )                                                            |   |                                    | 574    |                                      |   | (741                                                          | )      |   | (1,973 | ) |   | (27,849 | ) |
| Balance      as of April 30, 2009    |   | $                                            | 412     |                                                         |   | $                                       | 100    |                                      | $      | (741                                                          | )      | $ | (17,050 | ) | $ | (17,279 | ) |

----

|                                                                                                     | Qualified Plan |    |   | Nonqualified Plan |    |
|----------------------------------------------------------------------------------------------------------|---------------------|---------|--------|------------------------|---------|
| In      thousands                                                                                        | 2009                |    | 2008   |                   |    | 2009 |   |   | 2008 |   |
| Change      in benefit obligation:                                                                       |                |    |   |                   |    |   |   |   |   |   |
| Benefit      obligation at beginning of fiscal year                                                      | $                   | 103,992 |   | $                      | 104,175 |   |   | $ | 7,256 |   |   | $ | 7,274 |   |
| Service      cost                                                                                        |                | 2,289   |   |                   | 2,493   |   |   |   | 98 |   |   |   | 95 |   |
| Interest      cost                                                                                       |                | 6,622   |   |                   | 6,066   |   |   |   | 458 |   |   |   | 396 |   |
| Actuarial      (gain) loss                                                                               |                | (10,080 | )      |                   | (4,799  | ) |   |   | (362 | ) |   |   | 73 |   |
| Benefits      paid                                                                                       |                | (4,151  | )      |                   | (3,943  | ) |   |   | (513 | ) |   |   | (582 | ) |
| Impact      of curtailment                                                                               |                | (9,060  | )      |                   | ---     |   |   |   | (329 | ) |   |   | --- |   |
| Benefit      obligation at end of fiscal year                                                            | $                   | 89,612  |   | $                      | 103,992 |   |   | $ | 6,608 |   |   | $ | 7,256 |   |
|                                                                                                     |                |    |   |                   |    |   |   |   |   |   |   |   |   |   |
| Change      in plan assets:                                                                              |                |    |   |                   |    |   |   |   |   |   |   |   |   |   |
| Fair      value of plan assets at beginning of year                                                      | $                   | 82,197  |   | $                      | 82,142  |   |   | $ | --- |   |   | $ | --- |   |
| Actual      return on plan assets                                                                        |                | (17,918 | )      |                   | (1,442  | ) |   |   | --- |   |   |   | --- |   |
| Employer      contributions                                                                              |                | 5,906   |   |                   | 5,440   |   |   |   | 513 |   |   |   | 582 |   |
| Benefits      paid                                                                                       |                | (4,151  | )      |                   | (3,943  | ) |   |   | (513 | ) |   |   | (582 | ) |
| Fair      value of plan assets at end of fiscal year                                                     | $                   | 66,034  |   | $                      | 82,197  |   |   | $ | --- |   |   | $ | --- |   |
| Funded      status                                                                                       | $                   | (23,578 | )      | $                      | (21,795 | ) |   | $ | (6,608 | ) |   | $ | (7,256 | ) |
|                                                                                                     |                |    |   |                   |    |   |   |   |   |   |   |   |   |   |
| Amounts      recognized in balance sheets, before taxes:                                                 |                |    |   |                   |    |   |   |   |   |   |   |   |   |   |
| Other      accrued liabilities                                                                           | $                   | ---     |   | $                      | ---     |   |   | $ | (557 | ) |   | $ | (544 | ) |
| Accrued      pension benefit liability                                                                   |                | (23,578 | )      |                   | (21,795 | ) |   |   | (6,051 | ) |   |   | (6,712 | ) |
| Net      amount recognized                                                                               | $                   | (23,578 | )      | $                      | (21,795 | ) |   | $ | (6,608 | ) |   | $ | (7,256 | ) |
|                                                                                                     |                |    |   |                   |    |   |   |   |   |   |   |   |   |   |
| Amounts recognized in      Accumulated Other Comprehensive Income (Loss), before taxes, consist      of: |                |    |   |                   |
| Net      actuarial loss                                                                                  | $                   | 26,679  |   |                   | $       | 22,032 |   |   | $ | 492 |   |   | $ | 1,225 |   |
| Prior      service cost (credit)                                                                         |                | ---     |   |                   |    | 803 |   |   |   | --- |   |   |   | (34 | ) |
| Net      amount recognized                                                                               | $                   | 26,679  |   |                   | $       | 22,835 |   |   | $ | 492 |   |   | $ | 1,191 |   |

|                                |   | Qualified Plan |   | Nonqualified Plan |   |
|-------------------------------------|--------|---------------------|--------|------------------------|--------|
| In      thousands                   |   | 2009                |   |                   | 2008   |   |   | 2009 |   |   | 2008 |   |
| Projected      benefit obligation   |   | $                   | 89,612 |                   |   | $ | 103,992 |   |   | $ | 6,608 |   |   | $ | 7,256 |   |
| Accumulated      benefit obligation |   | $                   | 89,612 |                   |   | $ | 94,233 |   |   | $ | 6,608 |   |   | $ | 6,900 |   |
| Fair      value of plan assets      |   | $                   | 66,034 |                   |   | $ | 82,197 |   |   |   | --- |   |   |   | --- |   |

|                                                                     | Qualified Plan                       |   | Nonqualified Plan                    |   |
|--------------------------------------------------------------------------|-------------------------------------------|--------|-------------------------------------------|--------|
|                                                                     | For      the Fiscal Years Ended April 30, |   | For      the Fiscal Years Ended April 30, |   |
| In      thousands                                                        |                                      | 2009   |                                      |   | 2008 |   |   | 2007 |   |   | 2009 |   |   | 2008 |   |   | 2007 |   |
| Service      cost                                                        |                                      | $      | 2,289                                     |   |   | $ | 2,493 |   |   | $ | 2,361 |   |   | $ | 98 |   |   | $ | 95 |   |   | $ | 93 |   |
| Interest      cost                                                       |                                      |   | 6,622                                     |   |   |   | 6,066 |   |   |   | 5,874 |   |   |   | 458 |   |   |   | 396 |   |   |   | 427 |   |
| Expected      return on plan assets                                      |                                      |   | (6,838                                    | )      |   |   | (7,044 | ) |   |   | (6,132 | ) |   |   | --- |   |   |   | --- |   |   |   | --- |   |
| Amortization      of:         Prior service cost (credit) |                                      |   | 296                                       |   |   |   | 296 |   |   |   | 296 |   |   |   | (3 | ) |   |   | (3 | ) |   |   | (2 | ) |
| Actuarial      loss                                                      |                                      |   | 970                                       |   |   |   | 614 |   |   |   | 730 |   |   |   | 42 |   |   |   | 4 |   |   |   | 22 |   |
| Curtailment      loss (gain)                                             |                                      |   | 507                                       |   |   |   | --- |   |   |   | --- |   |   |   | (32 | ) |   |   | --- |   |   |   | --- |   |
| Net      periodic benefit cost                                           |                                      | $      | 3,846                                     |   |   | $ | 2,425 |   |   | $ | 3,129 |   |   | $ | 563 |   |   | $ | 492 |   |   | $ | 540 |   |

----

| In      thousands                                               | Qualified Plan |   | Nonqualified Plan |   |
|-----------------------------------------------------------------|---------------------|--------|------------------------|--------|
| Current      year actuarial loss (gain)                         |                | $      | 14,677                 |   |   | $ | (362 | ) |
| Amortization      of net actuarial loss                         |                |   | (970                   | )      |   |   | (42 | ) |
| Amortization      of prior service (cost) credit           |                |   | (296                   | )      |   |   | 3 |   |
| Effect      of curtailment:                                     |                |   |                   |   |   |   |   |   |
|   Curtailment      gain in other comprehensive income |                |   | (9,060                 | )      |   |   | (330 | ) |
|   Unrecognized      prior service (cost) credit       |                |   | (507                   | )      |   |   | 32 |   |
| Total      recognized in other comprehensive income             |                | $      | 3,844                  |   |   | $ | (699 | ) |

| In      thousands       | Qualified Plan |   | Nonqualified Plan |   |
|-------------------------|---------------------|--------|------------------------|--------|
| Net      actuarial loss |                | $      | 611                    |   |   | $ | --- |   |

|                                |   | Qualified      Plan |   |   | Nonqualified      Plan |
|-------------------------------------|--------|---------------------|--------|--------|------------------------|
| Benefit      Obligation Assumptions |   | 2009                |   |   | 2008                   |   |   | 2009 |   |   | 2008 |   |
| Discount      rate                  |   |                | 7.25   | %      |                   |   | 6.50 | % |   |   | 7.25 | % |   |   | 6.50 | % |
| Rate      of compensation increase  |   |                | *      |   |                   |   | 4.00 | % |   |   | * |   |   |   | 4.00 | % |

|                                |   | Qualified Plan                       |   |   | Nonqualified Plan                    |   |
|-------------------------------------|--------|-------------------------------------------|--------|--------|-------------------------------------------|--------|
|                                |   | For      the fiscal years ended April 30, |   |   | For      the fiscal years ended April 30, |   |
| Net      Cost Assumptions           |   | 2009                                      |   |   | 2008                                      |   |   | 2007 |   |   | 2009 |   |   | 2008 |   |   | 2007 |   |
| Discount      rate                  |   |                                      | 6.50   | %      |                                      |   | 6.00 | % |   |   | 6.25 | % |   |   | 6.50 | % |   |   | 6.00 | % |   |   | 6.25 | % |
| Expected      return on plan assets |   |                                      | 8.25   | %      |                                      |   | 8.50 | % |   |   | 8.50 | % |   |   | --- |   |   |   | --- |   |   |   | --- |   |
| Rate      of compensation increase  |   |                                      | 4.00   | %      |                                      |   | 4.00 | % |   |   | 4.00 | % |   |   | 4.00 | % |   |   | 4.00 | % |   |   | 4.00 | % |

----

|                                      |   | 2009   |   |   | 2008   |   |
|-------------------------------------------|--------|--------|--------|--------|--------|--------|
| Equity      securities                    |   |   | 51     | %      |   |   | 53 | % |
| Debt      securities                      |   |   | 40     | %      |   |   | 39 | % |
| Real      estate                          |   |   | 5      | %      |   |   | 5 | % |
| Other      (primarily money market funds) |   |   | 4      | %      |   |   | 3 | % |
|                                      |   |   | 100    | %      |   |   | 100 | % |

| In      thousands           | Qualified      Plan |   | Nonqualified      Plan |   |
|-----------------------------|---------------------|--------|------------------------|--------|
| Fiscal      Year 2010       |                | $      | 4,414                  |   |   | $ | 557 |   |
| Fiscal      Year 2011       |                | $      | 4,588                  |   |   | $ | 554 |   |
| Fiscal      Year 2012       |                | $      | 4,790                  |   |   | $ | 551 |   |
| Fiscal      Year 2013       |                | $      | 5,182                  |   |   | $ | 555 |   |
| Fiscal      Year 2014       |                | $      | 5,414                  |   |   | $ | 550 |   |
| Fiscal      Years 2015-2019 |                | $      | 30,984                 |   |   | $ | 2,846 |   |

----

|                                              | For      the Fiscal Years Ended April 30, |   |
|---------------------------------------------------|-------------------------------------------|--------|
| In      thousands                                 |                                      | 2009   |   |   | 2008 |   |
| Beginning      balance                            |                                      | $      | 2,327 |   |   | $ | 2,337 |   |
| Warranties      issued in the current period      |                                      |   | 5,036 |   |   |   | 5,880 |   |
| Impact      of business acquisitions (See Note 5) |                                      |   | 669 |   |   |   | --- |   |
| Reductions      for costs incurred                |                                      |   | (5,217 | ) |   |   | (5,890 | ) |
| Ending      balance                               |                                      | $      | 2,815 |   |   | $ | 2,327 |   |

----

| Level 2 | Quoted      prices for similar assets or liabilities in active markets or inputs that      are observable for the asset or liability, either directly or indirectly      through market corroboration, for substantially the full term of the      financial instrument. |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   In      thousands       |   | Total  |   |    | Quotedprices      inactivemarkets(Level      1) |   | Significantotherobservableinputs(Level      2) |   |   | Significantunobservableinputs(Level      3) |   |
|-------------------------------------|--------|--------|--------|---------|-------------------------------------------------|--------|------------------------------------------------|--------|--------|---------------------------------------------|--------|
| Interest      rate swap agreements  |   | $      | (1,181 | )  |                                            | $      | ---                                            |   |   | $                                           | (1,181 | )  |   | $ | --- |   |
| Available      for sale investments |   |   | 2,955  |    |                                            |   | 2,955                                          |   |   |                                        | ---    |   |   |   | --- |   |
|     Total       |   | $      | 1,774  |    |                                            | $      | 2,955                                          |   |   | $                                           | (1,181 | ) |   | $ | --- |   |

----

|                                     |   | For      the Fiscal Years Ended April 30, |    |
|------------------------------------------|--------|-------------------------------------------|---------|
| In      thousands                        |   | 2009                                      |    |   | 2008 |   |   | 2007 |   |
| Sign      Making and Specialty Graphics: |   |                                      |    |   |   |   |   |   |   |
| Gerber      Scientific Products          |   | $                                         | 89,712  |   |   | $ | 102,689 |   |   | $ | 89,357 |   |
| Spandex                                  |   |                                      | 230,993 |   |   |   | 258,397 |   |   |   | 212,730 |   |
| Sign      Making and Specialty Graphics  |   |                                      | 320,705 |   |   |   | 361,086 |   |   |   | 302,087 |   |
| Apparel      and Flexible Materials      |   |                                      | 174,566 |   |   |   | 207,945 |   |   |   | 196,164 |   |
| Ophthalmic      Lens Processing          |   |                                      | 57,543  |   |   |   | 70,986 |   |   |   | 76,547 |   |
| Consolidated      revenue                |   | $                                         | 552,814 |   |   | $ | 640,017 |   |   | $ | 574,798 |   |
|                                     |   |                                      |    |   |   |   |   |   |   |   |   |   |
| Sign      Making and Specialty Graphics: |   |                                      |    |   |   |   |   |   |   |   |   |   |
| Gerber      Scientific Products          |   | $                                         | (1,741  | ) |   | $ | 1,376 |   |   | $ | 5,199 |   |
| Spandex                                  |   |                                      | 9,559   |   |   |   | 10,592 |   |   |   | 6,419 |   |
| Sign      Making and Specialty Graphics  |   |                                      | 7,818   |   |   |   | 11,968 |   |   |   | 11,618 |   |
| Apparel      and Flexible Materials      |   |                                      | 12,059  |   |   |   | 26,681 |   |   |   | 27,601 |   |
| Ophthalmic      Lens Processing          |   |                                      | 3,198   |   |   |   | 4,384 |   |   |   | 2,913 |   |
| Segment      operating income            |   |                                      | 23,075  |   |   |   | 43,033 |   |   |   | 42,132 |   |
| Corporate      operating expenses        |   |                                      | (16,840 | ) |   |   | (17,984 | ) |   |   | (18,500 | ) |
| Total      operating income              |   | $                                         | 6,235   |   |   | $ | 25,049 |   |   | $ | 23,632 |   |

| In      thousands                  | United      States |   |    | Europe |   | All      Other |    |   | Total  |   |
|------------------------------------|--------------------|--------|---------|--------|--------|----------------|---------|--------|--------|--------|
| 2009                               |               |   |    |   |   |           |    |   |   |   |   |   |
| Revenue                            |               | $      | 175,114 |   |   | $              | 248,524 |   |   | $      | 129,176 |   |   | $ | 552,814 |   |
| Property,      plant and equipment |               | $      | 19,020  |   |   | $              | 15,101  |   |   | $      | 2,998 |   |   | $ | 37,119 |   |
|                               |               |   |    |   |   |           |    |   |   |   |   |   |   |   |   |   |
| 2008                               |               |   |    |   |   |           |    |   |   |   |   |   |   |   |   |   |
| Revenue                            |               | $      | 163,099 |   |   | $              | 292,252 |   |   | $      | 184,666 |   |   | $ | 640,017 |   |
| Property,      plant and equipment |               | $      | 18,440  |   |   | $              | 17,986  |   |   | $      | 3,426 |   |   | $ | 39,852 |   |
|                               |               |   |    |   |   |           |    |   |   |   |   |   |   |   |   |   |
| 2007                               |               |   |    |   |   |           |    |   |   |   |   |   |   |   |   |   |
| Revenue                            |               | $      | 157,600 |   |   | $              | 243,564 |   |   | $      | 173,634 |   |   | $ | 574,798 |   |
| Property,      plant and equipment |               | $      | 16,775  |   |   | $              | 17,554  |   |   | $      | 2,653 |   |   | $ | 36,982 |   |

----

| In      thousands | Building      andOffice      Space |   | Machinery      andEquipment |   |   | Total  |   |
|-------------------|------------------------------------|--------|-----------------------------|--------|--------|--------|--------|
| 2010              |                               | $      | 10,337                      |   |   | $      | 1,362  |   |   | $ | 11,699 |   |
| 2011              |                               |   | 8,441                       |   |   |   | 860    |   |   |   | 9,301 |   |
| 2012              |                               |   | 7,322                       |   |   |   | 422    |   |   |   | 7,744 |   |
| 2013              |                               |   | 6,349                       |   |   |   | 86     |   |   |   | 6,435 |   |
| 2014              |                               |   | 5,783                       |   |   |   | ---    |   |   |   | 5,783 |   |
| After      2014   |                               |   | 18,449                      |   |   |   | ---    |   |   |   | 18,449 |   |
|              |                               | $      | 56,681                      |   |   | $      | 2,730  |   |   | $ | 59,411 |   |

----

|                                            |   | April      30, 2009 |   |   | April      30, 2008 |   |   | April      30, 2007 |   |
|-------------------------------------------------|--------|---------------------|--------|--------|---------------------|--------|--------|---------------------|--------|
| In      thousands except per share amounts      |   | NetIncome           |   |   | AverageShares       |   |   | PerShare            |   |   | NetIncome |   |   | AverageShares |   |   | PerShare |   |   | NetIncome |   |   | AverageShares |   |   | PerShare |   |
| Basic      earnings per share                   |   | $                   | 2,236  |   |                |   | 23,561 |                |   | $ | 0.09 |   |   | $ | 14,504 |   |   |   | 23,320 |   |   | $ | 0.62 |   |   | $ | 13,508 |   |   |   | 22,896 |   |   | $ | 0.59 |   |
| Effect      of dilutive options and awards |   |                | ---    |   |                |   | 112    |                |   |   | --- |   |   |   | --- |   |   |   | 278 |   |   |   | (0.01 | ) |   |   | --- |   |   |   | 550 |   |   |   | (0.01 | ) |
| Diluted      earnings per share                 |   | $                   | 2,236  |   |                |   | 23,673 |                |   | $ | 0.09 |   |   | $ | 14,504 |   |   |   | 23,598 |   |   | $ | 0.61 |   |   | $ | 13,508 |   |   |   | 23,446 |   |   | $ | 0.58 |   |

| In      thousands except per share amounts |   | FirstQuarter |    |   | SecondQuarter |   |    | ThirdQuarter |   |   | FourthQuarter |   |
|--------------------------------------------|--------|--------------|---------|--------|---------------|--------|---------|--------------|--------|--------|---------------|--------|
| Fiscal      2009                           |   |         |    |   |          |   |    |         |   |   |          |   |
| Revenue                                    |   | $            | 158,858 |   |          | $      | 153,758 |         |   | $      | 120,097       |   |   | $ | 120,101 |   |
| Gross      profit                          |   | $            | 42,044  |   |          | $      | 43,594  |         |   | $      | 35,519        |   |   | $ | 33,221 |   |
| Net      income (loss)                     |   | $            | 681     |   |          | $      | 6,094   |         |   | $      | (2,232        | )      |   | $ | (2,307 | ) |
| Earnings      (Loss) per common share:     |   |         |    |   |          |   |    |         |   |   |          |   |   |   |   |   |
| Basic                                      |   | $            | 0.03    |   |          | $      | 0.26    |         |   | $      | (0.09         | )      |   | $ | (0.10 | ) |
| Diluted                                    |   | $            | 0.03    |   |          | $      | 0.26    |         |   | $      | (0.09         | )      |   | $ | (0.10 | ) |
| Fiscal      2008                           |   |         |    |   |          |   |    |         |   |   |          |   |   |   |   |   |
| Revenue                                    |   | $            | 153,667 |   |          | $      | 160,716 |         |   | $      | 151,966       |   |   | $ | 173,668 |   |
| Gross      profit                          |   | $            | 45,461  |   |          | $      | 46,396  |         |   | $      | 43,453        |   |   | $ | 51,223 |   |
| Net      income                            |   | $            | 2,837   |   |          | $      | 2,501   |         |   | $      | 3,063         |   |   | $ | 6,103 |   |
| Earnings      per common share:            |   |         |    |   |          |   |    |         |   |   |          |   |   |   |   |   |
| Basic                                      |   | $            | 0.12    |   |          | $      | 0.11    |         |   | $      | 0.13          |   |   | $ | 0.26 |   |
| Diluted                                    |   | $            | 0.12    |   |          | $      | 0.11    |         |   | $      | 0.13          |   |   | $ | 0.26 |   |

----

SIGNATURES

| GERBER SCIENTIFIC,      INC. |
|------------------------------|
| (Registrant)                 |
|                         |   |   |
| July      7, 2009            |   | By: | /s/  John J.      Krawczynski                              |
|                         |   |   | John      J. Krawczynski(Duly      Authorized Officer and Principal Accounting  Officer) |

| Date              | Signature                                            | Title                                                                                        |
|-------------------|------------------------------------------------------|----------------------------------------------------------------------------------------------|
| July      7, 2009 | /s/ Marc T.      Giles(Marc      T. Giles)           | President,      Chief Executive Officer and Director (Principal Executive      Officer)      |
|              |
|              |                                                 |                                                                                         |
| July      7, 2009 | /s/ Michael R.      Elia(Michael      R. Elia)       | Executive      Vice President and Chief Financial Officer (Principal Financial      Officer) |
|              |                                                 |                                                                                         |
| July      7, 2009 | /s/ Donald P.      Aiken(Donald      P. Aiken)       | Director,      Chairman                                                                      |
|              |                                                 |
|              |                                                 |                                                                                         |
| July      7, 2009 | /s/ Edward G.      Jepsen(Edward      G. Jepsen)     | Director                                                                                     |
|              |                                                 |
|              |                                                 |                                                                                         |
| July      7, 2009 | /s/ Randall D.      Ledford(Randall      D. Ledford) | Director                                                                                     |
|              |                                                 |
|              |                                                 |                                                                                         |
| July      7, 2009 | /s/ John R.      Lord(John      R. Lord)             | Director                                                                                     |
|              |                                                 |
|              |                                                 |                                                                                         |
| July      7, 2009 | /s/ Carole F. St.      Mark(Carole      F. St. Mark) | Director                                                                                     |
|              |                                                 |
|              |                                                 |                                                                                         |
| July      7, 2009 | /s/ W. Jerome      Vereen(W.      Jerome Vereen)     | Director                                                                                     |

----